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I keep six honest serving men, 
       (they thought me all I knew). 
       Their names are what, why, and when 
       and how and where and who. 
 
       Rudyard Kipling 
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1 Preface 
1.1 Abbreviations 
BHR  bronchial hyperresponsiveness 
BO  bronchial obstruction 
CD  cluster of differentiation 
CI  confidence interval 
DRS  dose-response-slope (by inhaled methacholine dose) 
ECA  the Environment and Childhood Asthma Study 
EAACI  the European Academy of Allergology and Clinical Immunology 
ECHRS the European Community Respiratory Health Survey 
ELISA  enzyme-linked immunosorbent assay 
EU  endotoxin unit 
FEV1  forced expiratory volume in 1 second  
FEF50  forced expiratory flow at 50% of forced vital capacity  
GA2LEN the Global Allergy and Asthma European Network 
GM  geometric mean  
HDM  house dust mite 
Ig  immunoglobulin 
IRAS  Institute for Risk Assessment Sciences 
ISAAC  the International Study on Asthma and Allergies in Childhood 
LAL  Limulus Amebocyte Lysate  
OR  odds ratio 
PD20  provocation dose of methacholine causing 20% fall in FEV1
PIAMA the Prevention and Incidence of Asthma and Mite Allergy Study 
rBO  recurrent bronchial obstruction 
SD  standard deviation 
SPT  skin prick test 
Th  T helper cells 
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1.2 Summary
Introduction
The observed rapid increase in asthma prevalence over the past decades in Western societies 
has been attributed to numerous factors, including increased awareness of the disease, altered 
lifestyle and activity patterns, and changes in indoor and outdoor environmental exposures. 
Modern houses with effective insulation have reduced the natural, passive air exchange with 
consequently increased exposure to indoor allergens and pollutants. In areas with low 
exposure to mites and cockroaches, exposure to cat and dog allergens are thought to be more 
important for susceptible individuals in relation to allergic disease.  
 
The main aim of the present study was to improve our knowledge about the association of the 
indoor environment and the development of allergic disease in Norwegian children.  
 
The specific research questions were:  
1. Is pet exposure influenced by a family history of allergic disease?  
2. Is exposure to furred pets associated with development of allergic diseases?  
3. Does exposure to house dust mite and microbial components influence the 
development of allergic diseases?  
4. Do boys and girls differ with respect to exposure and in exposure-disease 
associations?  
 
Methods
The present thesis reports results from the prospective birth cohort the Environment and 
Childhood Asthma Study (ECA) established in Oslo in 1992, with 3754 infants enrolled. 
Starting at the maternity ward, extensive questionnaires were completed by the parents every 
six months for the first two years of the children’s life. At 2 years of age, all parents were 
invited to submit house dust samples. At 10 years of age 1215 children were invited to 
participate in a follow-up study. These children had either had lung function measured at birth 
(n=802) and/or had participated in a nested case-control study at 2 years of age (n=562) (cases 
being children with recurrent bronchial obstruction during the two first years of life). Overall, 
1019/1215 (84%) children attended the 10-year follow-up study with clinical examination, 
measurement of lung function, bronchial responsiveness, exercise tests, skin prick tests, 
extensive parental interview and dust sampled from the child’s bed.   
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Results
Pet keeping at the child’s birth was not associated with a family history of allergic disease. At 
the 10-year follow-up study, 24% of the parents failed to report the pet they had kept during 
the child’s first year of life according to the prospective questionnaires. Furthermore, single 
parenthood, parental smoking, and having older siblings all significantly increased the 
likelihood of acquiring pets after birth, whereas high parental education levels increased the 
likelihood of pet avoidance. Overall, 319 parents reported pet avoidance due to allergic 
disease in the family or the wish to prevent allergic disease in the child. Recurrent or 
persistent bronchial obstruction early in life and doctor diagnosed asthma at 10 years of age 
did not prevent the families from acquiring furry pets. However, doctor diagnosed allergic 
rhinoconjunctivitis before the age of 10 years was a strong determinant for never having kept 
cats or dogs and for reporting pet avoidance. 
For 260 eligible children with lung function measured at birth and house dust sampled 
at 2 years of age, the odds of current asthma at 10 years increased with 1.20 (95% CI: 1.01, 
1.43) per 10 μg/g increase in cat allergen (Feld d1) levels at 2 years. At 10 years of age, 
34.4% of the children were sensitized to at least one inhalant allergen, and 17.8% were 
sensitized to both seasonal and perennial allergens. The majority of the children sensitized to 
cat and dog allergens at 10 years of age had never kept cats or dogs at home (85% and 91%, 
respectively).  
House dust mite (HDM) allergen, Der p1, was detected in only 12.3% of the 797 
mattress dust samples taken at age 10 years. Nevertheless, the children who were sensitized to 
Der p1 (8.8%) had significantly higher Der p1 levels in their mattress dust compared to 
children who were not sensitized. Early life exposure to dog allergen (Can f1), ß(1,3)-glucans, 
and endotoxin did not modify the risk of allergic disease at 10 years of age.  
The 10-year old girls were more likely to keep cats and rodents compared to boys, and 
girls were also exposed to higher cat and dog allergen levels from mattress dust, regardless of 
pet ownership. Current rhinitis at 10 years of age (25.0% of all the 1019 children in the 
follow-up) was most often associated with allergic sensitization (72.8%). The children with 
current rhinitis were also more likely to suffer from multiple allergy-related co-morbidities 
like asthma, atopic eczema, and conjunctivitis (87.0% with at least one and 42.9% with at 
least two co-morbidities). The odds of current rhinitis increased with 1.20 (95% CI: 1.01, 
1.42) per 1 μg/g increase in HDM allergen level in mattress dust for girls, but not for boys.  
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Conclusions
1. The results presented in this thesis show that families with children with allergic rhinitis 
often avoided owing cats and dogs. On the other hand, a family history of allergic disease did 
not significantly decrease the likelihood of pet keeping at the child’s birth. Reported pet 
avoidance appeared to be most common in families where the parents had high education, 
whereas pet removal was found to be uncommon in the present cohort. 
2. Increased cat allergen levels in homes at 2 years of age increased the risk of asthma at 10 
years of age, whereas no association was seen with allergic sensitization at the age of 10. Cat 
and dog allergen levels in mattress dust at 10 years of age were not associated with concurrent 
symptoms of rhinitis.   
3. House dust mite allergen levels in homes in Oslo were generally low, but children 
sensitized to Der p1 had significantly higher levels of Der p1 in their mattress dust compared 
to those who were not sensitized. Endotoxin and ß(1,3)-glucan levels in house dust measured 
at 2 years of age did not modify the allergen or pet-related risk of allergic disease or lung-
function at 10 years of age. 
4. Girls were more likely to keep furry pets and were also exposed to higher cat and dog 
allergen levels at 10 years of age. However, in the multivariate analyses, levels of HDM 
allergen, but not cat or dog allergens, were associated with an increased risk of current 
rhinitis, but this was observed among the girls only.  
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2 General introduction and background 
The work in the present thesis was performed within the Environment and Childhood Asthma 
Study (ECA), which comprises a number of completed and ongoing subprojects. The present 
subproject has its focus on the possible role of certain indoor environmental factors on the 
development of allergic sensitization, rhinitis and asthma. The collections of information by 
questionnaires, clinical examinations and serum analyses, as well as the definitions of asthma 
and rhinitis were previously defined as part of the ECA study. The present subproject 
concerns the laboratory analysis of dust samples for common indoor allergens and microbial 
components, the relationship between exposure to these agents and health outcomes, 
considering the impact of personal, social and environmental factors. The laboratory and 
epidemiological analyses are the particular responsibilities of the author.  
2.1 Allergic disease
2.1.1 Definitions 
Allergic disease is a collective term which is often used to describe health outcomes 
associated with reactions to allergens such as atopic eczema, urticaria, wheezing, rhinitis, 
conjunctivitis, asthma, contact dermatitis and food allergies. However, most of these 
conditions may also be triggered by non-allergic factors like infections, exercise, irritants, 
climatic factors and emotional stress (Brunetti et al., 2007; Carlsen and Carlsen, 2008; 
Fokkens, 2002).  
A nomenclature proposal prepared by representatives of the European Academy of 
Allergology and Clinical Immunology (EAACI) has defined ‘allergy’ as “a hypersensitivity
reaction initiated by specific immunological mechanisms” (Johansson et al., 2004) and 
‘hypersensitivity’ by “objectively reproducible symptoms or signs, initiated by exposure to a 
defined stimulus at a dose tolerated by normal subjects”. ‘Atopy’ is presently defined as “a 
personal or familiar tendency to produce IgE antibodies in response to low doses of 
allergens, usually proteins, and to develop typical symptoms such as asthma, 
rhinoconjunctivitis, and eczema/dermatitis” (Johansson et al., 2004). However, exposure to 
elevated immunoglobulin E (IgE) levels against a specific allergen does not necessarily lead 
to clinical symptoms, and allergens may cause symptoms in individuals without detectable 
IgE in serum (Bodtger et al., 2006). In the present work, the main focus will be on exposure 
to indoor allergens and microbial components that may influence IgE-mediated 
hypersensitivity in susceptible individuals, with particular emphasis on asthma and rhinitis as 
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defined in the individual papers. In the present work allergic sensitization is defined by a 
positive allergy test and allergic disease when in combination with symptoms.  
2.1.2 Specific IgE and allergic reactions 
Host defense mechanisms consist of innate and adaptive immunity. Innate immunity mediates 
the initial protection against infections and foreign molecules entering the body, whereas 
adaptive immunity in response to the first exposure, develops more slowly and mediates the 
later and more effective defense specifically tailored to combat the intruder (Abbas and 
Lichtman, 2006). Furthermore, the adaptive immune response provides the immune system 
with the ability to remember and quickly recognize specific pathogens and molecules, to 
mount faster, stronger and a more efficient defense the next time the pathogen is encountered.  
IgE antibodies are part of the specific immune system, and represent one of five 
immunoglobulin classes that have very different functional properties (IgD, IgM, IgG, IgA 
and IgE). Antibody production by B cells (differentiating into plasma cells) is largely 
regulated by T helper cells. The adaptive immune system may respond by different helper T 
cell responses, like Th1 and Th2 (Murphy et al., 2008). They are each designed to eliminate 
different types of pathogens. The Th1-dominated immune response activates a cell-mediated
immunity and also certain types of humoral (antibody-mediated) immunity characterized by 
activation of cytotoxic T cells and macrophages as well as production of opsonising IgG1 
antibodies. The Th1 response is important in the defence against infections (intracellular and 
many extracellular pathogens), and also mediates delayed-type hypersensitivity reactions and 
causes organ-specific auto-immune diseases. The Th2-dominated immune response is 
characterized by a certain type of humoral immunity which stimulates antibody-mediated 
responses of particular immunoglobulin classes (IgE and IgG4) and is important in the 
defence against parasites, toxins and to some extent extracellular microbes, and also mediate 
classic (IgE-mediated) immediate-type allergic responses. Antibodies prevent infection by 
blocking the ability of microbes to bind to and infect the host cells (in particular IgA), by 
promoting phagocytosis and intracellular killing of microbes (opsonisation), and by 
complement activation which may directly kill the microbe. Antibodies also bind to microbial 
toxins and prevent them from damaging host cells. Immediate-type allergic reactions are 
caused by IgE-mediated mast cell activation and release of potent mediators like histamine, 
prostaglandins and leukotriens. Also basophils have IgE receptors on their cell surface and 
have similar functions as mast cells in allergic reactions. However, as mast cells have been 
more thoroughly described, the main focus will be on these cells in the remainder of the 
  9 
General introduction and background 
___________________________________________________________________________ 
chapter. The classic Th1/Th2 paradigm has recently been revised due to the identification of 
novel helper T cell-subsets like Th17 cells and different regulatory T cells. Th17 cells have a 
role in clearing specific types of infectious organisms (for example Klebsiella) and in the 
development of autoimmune diseases (Miossec et al., 2009). Th17 has also been proposed as 
a new marker for classification of non-allergic types of asthma (Oboki et al., 2008). T 
regulatory cells are important in preventing excessive reactions in the immune system by 
suppressing immune responses and inflammatory reactions (Ozdemir et al., 2009). 
The allergic reaction, like all immune reactions, result from two temporally distinct 
processes, the sensitization phase (allergen encounter with development of the immune 
response) and the challenge phase (subsequent allergen encounter by the sensitized 
individual) (figure 1). In the sensitization phase, allergens enter via the mucosal surface and 
the skin and are taken up by dendritic cells, processed and then presented to naïve T 
lymphocytes. If antigen specific T lymphocytes recognize the epitopes on the allergen 
through their receptors and the proper co-stimulatory factors are present, the T lymphocytes 
are stimulated to proliferate and differentiate into Th2 lymphocytes. Th2 lymphocytes release 
a number of cytokines including interleukin 4 (IL-4) and IL-13, both of which are critical to 
the production of IgE by B lymphocytes, and IL-5 which is important for the recruitment and 
activation of eosinophils (Owen, 2007). The B lymphocyte differentiates into either memory 
B cells or plasma cells. Plasma cells reside in the bone marrow and continue to produce IgE. 
The IgE molecules bind to the high-affinity IgE receptors on mast cells and basophile cells 
which then become sensitized. 
Both IgE and mast cells are concentrated in the mucosal tissues, and IgE antibodies 
are among the first defense molecules that an allergen encounters. When allergen cross-binds 
specific IgE bound to the IgE receptors of mast cells, the mast cells become activated, which 
in turn leads to degranulation and release of allergic mediators. This causes an inflammatory 
response, the “early response” of the immediate reaction. The cytokines and mediators 
released in the early phase initiate the later response, as the site of inflammation becomes 
infiltrated with effector cells such as Th2 cells, eosinophils, and other cells, causing a second 
wave of reaction (“late phase reaction”) (Gould and Sutton, 2008). The allergic 
hypersensitivity reactions reveal itself in characteristic signs and symptoms in the different 
target organs of allergy, the skin (such as urticaria and eczema), the nose (rhinitis), the lungs 
(asthma) and the gut (food allergic reactions) (Gould and Sutton, 2008). Reactions may be 
local in the challenged organ, but can also become systemic and affect more than one organ 
(anaphylaxis).  
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etc.)
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inflammation:
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Figure 1:  Schematic illustration of immunological mechanisms involved in development of allergic 
reactions
 
Inhalation is a common route of allergen entry, and reactions to inhaled antigens with 
sneezing and a runny nose is often referred to as allergic rhinitis. Allergic rhinitis is 
characterized by intense itching and sneezing, local edema leading to blocked nasal passage, a 
clear nasal discharge, typically rich in eosinophils, and irritation of the nose as a result of 
histamine release (Murphy et al., 2008). A similar reaction to airborne allergens deposited on 
the conjunctiva of the eyes is called allergic conjunctivitis. 
 Asthma is a chronic inflammatory airway disease characterized by bronchial 
hyperresponsiveness and reversible obstruction of airflow caused by contraction of the 
smooth muscles of the airways, oedema of the mucosa, excess mucus production, and chronic 
inflammation (Masoli et al., 2004; Owen, 2007). The symptoms of bronchial asthma consist 
of recurrent episodes of wheezing, breathlessness and chest tightness which may cause 
considerable limitations and distress in the lives of those who suffer from this disease (Masoli
et al., 2004). However, it should be noted that all the above mentioned allergic diseases 
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(urticaria, rhinitis, conjunctivitis, asthma, and food allergy), may also be caused by non-
allergic (non-IgE) mechanisms.  
2.1.3 Diagnosis of allergic diseases and IgE detection
A variety of laboratory tests now exist to diagnose IgE-mediated conditions. Total IgE may 
indicate allergic inflammation, but may also show large variations between geographical areas 
and different populations (Burney et al., 1997). Moreover, normal levels of total IgE does not 
exclude the presence of allergic disease (Sanz et al., 1996). The most commonly used tests for 
determining the presence of allergen-specific IgE mediated inflammation are the skin prick 
tests (SPT) (Dreborg and Frew, 1993) and in vitro analysis for the presence and levels of 
specific IgE in serum (sIgE) (Tschopp et al., 1998). SPT indirectly measures sIgE bound to 
mast cells/basophils in the skin where a single allergen molecule must simultaneously cross-
bind two IgE molecules to cause a reaction. In an in vitro sIgE assay, the binding is 
monovalent and a single IgE molecule binds one epitope (antigenic binding site) to generate a 
reaction. Although IgE antibodies are produced as a response to the exposure from a specific 
allergen, cross-binding may occur in which the sIgE binds to other allergens with similar 
epitopes (Malandain, 2004; Reininger et al., 2007). Cross-reactivity may thus have 
consequences for sIgE as diagnostic tools, and a careful patient’s history in addition to the 
quantitative sIgE results is vital for diagnosing clinical allergy. A more important issue for the 
patient is that cross-binding to allergens with similar epitopes may lead to cross-allergies 
between food proteins, and also between food and pollen, the so-called oral allergy syndrome 
(Poulsen, 2005; Ricci et al., 2005).  
For both SPT and sIgE assays, more or less standardized allergen extracts are used, but 
the extracts may vary in potency from different manufacturers (Eichler et al., 1988). 
Moreover, the allergen extracts may have only a selection of the relevant fractions or 
antigenic determinants (epitopes) which are responsible for the clinical symptoms. Thus, 
patients may experience allergic symptoms without a positive allergy test. The agreement 
between SPT and sIgE assays is in general good, but discrepancies may occur (Sanz et al., 
1996). Higher concentrations of sIgE and/or increasing SPT wheal size are roughly correlated 
with an higher probability of clinical allergy (Asarnoj et al., 2008; Sicherer and Sampson, 
2006).  
Diagnosing allergic disease in children may be difficult because they are not always 
able to describe their symptoms (Lack, 2001). In asthma diagnosis, pulmonary function tests 
are important to document airflow limitations and are often used to confirm the presence of a 
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reversible bronchial obstruction after administration of a short-acting bronchodilator 
(Passalacqua and Ciprandi, 2008). However, such tests are difficult to perform in infants and 
young children who are unable to cooperate adequately. Thus, asthma in children younger 
than 6 years of age is commonly a clinical diagnosis, based on recurrent symptoms of airways 
obstruction such as cough, wheeze and shortness of breath. The presence of a family history 
of atopy, allergic sensitization and positive effects from asthma medication are used as 
additional indicators of asthma. However, in particular at pre-school age, symptoms such as 
sneezing, runny or blocked nose, as well as cough and wheezing may be caused by viral 
infections, which add to the difficulty of diagnosing asthma and rhinitis in young children 
(Eder et al., 2006; Lack, 2001).  
2.2 Personal risk factors 
2.2.1 Age 
In infants and young children, food allergy and atopic eczema are the most common allergic 
diseases (Sicherer and Sampson, 2006; Wuthrich, 1999). Sensitization to milk and egg 
allergens is usually outgrown, while peanut, tree nut, and seafood allergy often persist 
(Sicherer and Sampson, 2006). In later childhood, sensitization to inhalant allergens is more 
common than food sensitization (Hattevig et al., 1993). 
Atopic infants, however, are at risk of allergic diseases also later in life. It has been 
estimated that 35% of young children with atopic eczema have food allergy (Sicherer and 
Sampson, 2006), and this has further been proposed as the first step in a progressive “atopic 
march” that over time may lead to asthma and/or allergic rhinitis (Burgess et al., 2009; 
Gustafsson et al., 2000; Spergel and Paller, 2003). Wheezy infants with IgE antibodies to 
foods or inhalant allergens are reported to have increased risk of respiratory symptoms later in 
childhood (Kotaniemi-Syrjanen et al., 2003). Rhinitis often precedes the development of 
asthma (Cruz et al., 2007), but it is generally not clear whether one allergic disease leads to 
another allergic disease, or to what extent allergic sensitization is causative for or co-existing 
with rhinitis and asthma (Anto, 2004). Therefore, the term ‘atopic march’ should not be used 
to describe causal relationship, but rather the time sequence of disease manifestation. 
Nevertheless, diagnosing allergy in young children is important because it has prognostic 
implications and sets the basis for managements and preventive strategies (Sly et al., 2008).  
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2.2.2 Gender 
Boys and girls have different prevalence of asthma and allergy and appear also to differ in 
their response to the triggers of these diseases. Boys are consistently reported to have more 
prevalent asthma and allergies than girls before puberty. In adolescence, the pattern changes 
and a higher prevalence of asthma and allergies are found in females (Almqvist et al., 2008; 
Postma, 2007). Females appear to be under-diagnosed with regard to airway diseases, 
however, this has been found both in childhood and adulthood (Siersted et al., 1998; Yeatts et
al., 2003) and is therefore not likely to explain the gender differences. No single 
straightforward mechanism can explain the gender differences in allergic disease although 
extensive research has been focused on this topic. The differences are thus more likely to be a 
combination of physiology (Becklake and Kauffmann, 1999; Lowe et al., 2008), differences 
in susceptibility of environmental factors (Gold et al., 1996; Lodrup Carlsen et al., 2006b), 
and differences in risk factors, such as smoking and pet keeping (Bjerg et al., 2009; Chen et 
al., 2002). 
2.2.3 Genes 
The factors, which determine whether an allergen will trigger a Th1 or Th2 response, are not 
well understood, but as implied by the definition of atopy, allergic diseases have an important 
hereditary nature. For example, the risk of a child developing an IgE-mediated allergy is 40-
60% if both parents are allergic, and 5-10% if neither parent have allergy (Kjellman, 1977). 
This, however, have changed over the last decades and the risk for developing allergic disease 
for individuals without a hereditary predisposition is now believed to be much higher than 5-
10%. Parental asthma is also a risk factor for the development of early allergic sensitization in 
children (Crestani et al., 2004). For asthma, twin studies have demonstrated a considerable 
genetic component, but the genetic contribution differs for the different phenotypes of asthma 
(Los et al., 2001). Moreover, environmental exposure affecting individuals differently 
depending on their genotype, by so-called gene-by-environment interactions (Bruce et al., 
2009; Eder et al., 2004), are becoming clearly more evident. A model for such interactions is 
suggested by the endotoxin-CD14/Toll-like receptor interaction, indicating that the protective 
or detrimental effects exerted by specified genotypes on allergy or asthma depend upon the 
exposure levels (Eder et al., 2004). The importance of environmental factors are supported by 
numerous epidemiological studies showing major differences between populations that are 
not related to genetics alone, such as populations in Hong Kong vs other Chinese cities (The 
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International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee, 
1998; Wong et al., 2001) and populations in East vs West Germany (Ring et al., 1999). 
2.3 Environmental risk factors 
2.3.1 Geographical trends
Differences in climate, location (urban, rural), cultural and other life style factors all lead to 
different types of exposure that may have consequences for the development of allergic 
disease. The severity and high prevalence of asthma (>20%) observed in Australia, New 
Zealand, Taiwan, the UK and inner cities in the US, are proposed to be related to mite and 
cockroach exposure (Richardson et al., 2005) as well as to socio-economic factors. However, 
in other countries such as Sweden and Norway and in high-altitude locations where these 
potent allergens are absent, or present in very low concentrations, the prevalence of asthma is 
still high (Lodrup Carlsen et al., 2006a; Perzanowski et al., 1999; Sporik et al., 1995). In 
these regions, exposure to cat and dog allergens is hypothesized to be more strongly linked to 
asthma (Custovic et al., 1998; Perzanowski et al., 1999).  
Although sensitization to cat and dog allergens usually is more prevalent than to mite 
and cockroach in Scandinavian countries, pollen is often the dominant sensitizing allergen, in 
particular birch, due to relatively short periods of high birch pollen exposure (Bakken et al., 
2007; Omenaas et al., 1994). In Sweden, birch pollen was found to be the dominating inhalant 
allergen as early as 4 years of age (Asarnoj et al., 2008), and in the ISAAC study, Norwegian 
children had the highest prevalence of allergic sensitization to seasonal allergens among all 
the included populations (Weinmayr et al., 2008). The prevalence of allergic sensitization in 
asthmatics may also vary depending on geographical location, for example from 56.3% in 10 
year old children in Oslo (Lodrup Carlsen et al., 2006a) to 70.1% in Tuscon (Crestani et al., 
2004). The allergens needed to be included in test profiles to help identifying individuals with 
allergic disease, will vary depending on the subject’s place of residence as well as age 
(Wickman et al., 2005). In a recent Global Allergy and Asthma European Network 
(GA2LEN) study, as many as 18 different allergens had to be included in a skin test panel to 
appropriately assess sensitization across Europe (Bousquet et al., 2009). 
2.3.2 Time trends
The increase in allergic diseases has often been referred to as the Epidemic of the 21st 
Century. Asthma showed a marked increase in the decades between 1960 and 2000, in 
particular in affluent countries. Over the past decade, however, asthma prevalence seems to 
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have levelled out or even declined in some countries (Asher et al., 2006). A recent study from 
our study group in Oslo, Norway, demonstrated a life-time prevalence of asthma of 20.2% 
among 10 year old urban school children and current asthma in 11.1% (Lodrup Carlsen et al., 
2006a). This is the highest prevalence reported in Norway and shows an exponentially 
increasing trend from 0.4% in 1948 (Claussen, 1948).  
For allergic rhinoconjunctivitis, the pattern is complex, depicting a scenario where all 
three possibilities of increasing, decreasing or steady trends are present in various regions of 
the world (Asher et al., 2006). However, correct estimates of rhinoconjunctivitis in childhood 
are hampered by the lack of good age-specific diagnostic criteria and examinations, and the 
disease is usually defined by questionnaire data in which misclassification may occur 
(Phipatanakul, 2005), in that symptoms of rhinitis may be confused with symptoms of 
infections and colds. Problems may also occur in studies using objective methods such as skin 
prick test or allergen-specific IgE analyses as ‘positive’ tests indicate allergic sensitization, 
but not necessarily clinical disease (Phipatanakul, 2005). It has also been difficult to monitor 
trends in allergic sensitization, but it is generally accepted that the increase in asthma 
prevalence has been associated with a rise in allergic sensitization in the western societies 
(Braman, 2006). Furthermore, the prevalence of allergic sensitization has been found to 
increase in parallel in asthmatic and non-asthmatic subjects (Ronchetti et al., 2007). A recent 
study from northern Sweden reported a major increase in allergic sensitization in school 
children from 1996 to 2006 by comparing two population-based cohorts from the same 
Swedish towns established 10 years apart (Ronmark et al., 2009). The increase in allergic 
disease in many developed countries has been too rapid to account for corresponding changes 
in genetic susceptibility of the populations. It therefore seems likely that changes in 
environmental factors have had influence on the development of disease (von Mutius, 2000).  
2.3.3 Social trends and lifestyle factors 
In 1873 Charles Blackley observed that “catarrhus aestivus” (hay fever) was more common 
among the educated than the illiterate and he hypothesized that “as civilisation and education 
advance, the disorder will become more common than it is at the present time” (Blackley 
C.H., 1988). Still, more than a decade later, atopic diseases and allergic sensitization appear to 
be more frequent in the higher socio-economic classes within a community (Heinrich et al., 
1998; Williams et al., 1994). In contrast, more severe asthma (Volmer, 2001) and non-atopic 
conditions are more common in the lower socio-economic classes (Ellison-Loschmann et al., 
2007). Within the U.S., social trends have in part been attributed to non-compliance to 
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treatment and reduced access to healthcare services for the lower social classes (Volmer, 
2001). Other potential explanatory factors for differences between social classes may be 
differences in allergen types or lifestyle factors such as reduced physical activity, obesity, 
respiratory infections in childhood, smoking and exposure to tobacco smoke (Kitch et al., 
2000; Lannero et al., 2002).  
Social trends may also differ between countries and in Norway with government-
funded education and healthcare; there are no clear distinct social classes. Furthermore, 
asthmatic 13 year old adolescents from the present cohort were neither less physically active 
nor more obese than the non-asthmatics (Berntsen et al., 2009). Moreover, in two studies 
from Sweden, there were no clear socio-economic trend for allergic disease (Almqvist et al., 
2005; Braback et al., 2005), and the steepest increase in asthma and allergic rhinitis was 
observed in the lower socio-economic classes (Braback et al., 2005). In recent reports on 
world-wide trends on asthma the asthma prevalence appear to continue to rise sharply in 
developing regions with increasing urbanization and westernization (Asher et al., 2006; 
Braman, 2006). The prevalence rates of allergic disease may also depend upon increased 
awareness of symptoms and from the willingness of physicians to make the diagnosis and 
prescribe treatment (Barraclough et al., 2002; Eder et al., 2006; Phipatanakul, 2005). 
However, despite a different labeling of asthma, a comparative study between three countries 
(Sweden, Finland and Estonia) demonstrated similar frequency of symptoms in the study 
populations (Pallasaho et al., 2005). 
Because the affluent countries have witnessed the highest increase in asthma and 
allergies during the last decades, environmental and lifestyle factors associated with the 
‘modern’ or ‘western’ society have been suggested to influence the development of allergic 
disease (Von Hertzen and Haahtela, 2004). This has been supported by epidemiological 
studies reporting similar asthma prevalence trends between immigrant and non-immigrant 
children within the same area (Ponsonby et al., 2008), and increased prevalence of allergic 
disease among the children from East Germany after the fall of the Berlin wall (Heinrich et 
al., 2002). A similar East-West trend for asthma was observed in the ISAAC study for 
countries within Europe in 1998 (The International Study of Asthma and Allergies in 
Childhood (ISAAC) Steering Committee, 1998), whereas in 2003 this trend was clearly 
reduced (Asher et al., 2006). Some of the proposed explanatory factors are changes in the 
microbial burden “The Hygiene Hypothesis” (Strachan, 2000), the occupational environment 
(Mapp et al., 2005), a more sedentary lifestyle with changes in diet and physical activity 
(Alfredo et al., 2007; Flaherman and Rutherford, 2006; Marti et al., 2004), and increases in 
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traffic-related air pollutants (Braback and Forsberg, 2009; Gilmour et al., 2006; Heinrich and 
Wichmann, 2004).  
Air pollutants may act both as adjuvants or triggers of allergic disease (figure 2), and 
may together with climatic changes increase the abundance and effect of aeroallergens such as 
pollen (Gilmour et al., 2006). Air pollutants in the indoor environment, such as tobacco 
smoke has been consistently linked to the onset of asthma (Carlsen and Carlsen, 2008; Eder et 
al., 2006; Gilmour et al., 2006). Lately, there has been a growing concern related to the 
increased exposure to industrially produced chemicals such as bisphenol A and phthalates 
(Lakind and Naiman, 2008; Wittassek et al., 2007) that have been proposed to influence the 
development of allergic disease (Glue et al., 2005; Tian et al., 2003). 
 
Genetic susceptibility
Hypersensitivity
e.g. IgE-mediatied
Airway disesase
e.g. asthma, rhinitis
Exacerbation of disease
Adjuvants:
Tobacco smoke
Pollutants
Chemicals
Protective factors:
Breast feeding?
Microorganisms?
Nutrition?
Triggers:
Pollutants
Excercise
Infections
Allergens:
1. Indoor allergens:
House dust mite,
cockroaches, pets and
moulds
2. Outdoor allergens:
Pollens and moulds
3. Occupational allergens:
Enzymes, latex, flour,
urinary proteins from
rodents
 
Figure 2: Factors affecting the development and progression of allergic airway disease. Modified 
from (Nielsen G.D. et al., 2005)
2.3.4 The indoor environment
Today children spend more time indoors and are less physically active than for some decades 
ago. It is estimated that the Americans spend an average of 87% of their time indoors (Klepeis
et al., 2001), and in a study from Germany the mean average time the individuals spent 
indoors in their own home was 16 hours (Brasche and Bischof, 2005). The housing 
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characteristics have also changed during the last decades (Jacobs et al., 2009). Modern houses 
are better insulated which may cause an increase in indoor humidity and temperature. 
Increased dampness seems to be well documented and to be associated with airway symptoms 
and asthma, although the mechanism is not known (Bornehag et al., 2001; Bornehag et al., 
2004; Gilmour et al., 2006). Better insulation also leads to a dramatic reduction of the natural 
outdoor-indoor air exchange (Bornehag et al., 2005). Under these conditions, allergens and 
pollutants produced or present indoors will no be diluted by natural air circulation, with the 
consequence of an increase in exposure. 
2.3.5 Pet keeping and indoor allergens
The risk of developing allergic sensitization may be affected by the exposure level to indoor 
allergens. The dose-response relationship between allergen exposure and allergic sensitization 
may differ between allergens. A linear relationship for HDM and cockroach allergen exposure 
has been suggested, whereas for cat allergen exposure a bell-shaped curve leading to some 
form of immunological deviation and tolerance at the highest exposure levels has been 
proposed (Platts-Mills et al., 2004). However, a non-linear relationship between HDM 
allergen exposure (mean exposure over a five-year period) and HDM sensitization and asthma 
at 5 years of age, was recently reported from a birth cohort/intervention study in Australia 
(Tovey et al., 2008).  
In prospective cohort studies positive associations between HDM allergen exposure 
and sensitization has only been observed for high-risk children (children with parental history 
of allergic disease) (Celedon et al., 2007; Cole et al., 2004; Sporik et al., 1990) or in atopy-
enriched cohorts (Brussee et al., 2005; Wahn et al., 1997). For population-based studies the 
associations are weaker, but interestingly, the associations between HDM exposure and 
sensitization appear to rise steeply at low levels and levelling of at high levels of exposure 
(Cullinan et al., 2004; Torrent et al., 2006).  
With regard to pet allergens, similar associations as for HDM allergens have been seen 
in population-based studies for low levels of allergen exposure and sensitization, but with a 
lack of associations at high levels (Cullinan et al., 2004; Torrent et al., 2006). Moreover, 
several studies have reported exposure to cat allergens early in life to increases the risk of 
allergic sensitization to cat in children younger than 4 years of age (Brussee et al., 2005; Chen
et al., 2007; Sandin et al., 2004; Torrent et al., 2006; Wahn et al., 1997). In contrast, no 
association has been confirmed between dog allergen exposure and sensitization to dog 
(Brussee et al., 2005).  
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Several studies have reported impaired lung function in individuals sensitized and 
concomitant exposed to high levels of the sensitizing allergen (Illi et al., 2006; Lowe et al., 
2004) and allergic sensitization has repeatedly been found to be a risk factor for asthma (Illi
et al., 2006; Ingram et al., 1995; Lau et al., 2005; Platts-Mills et al., 2001). However, when 
the association between allergen exposure and asthma development are assessed without the 
inclusion of allergic sensitization, usually no association have been confirmed. One review 
article reported that no longitudinal studies of random populations published before the year 
2000 had been identified in which allergen exposure during infancy could be related to 
asthma risk after the age of 6 years (Pearce et al., 2000). The majority of the later publications 
have also been unable to demonstrate an association between early life exposure to allergens 
and the development of asthma (Brussee et al., 2005; Cullinan et al., 2004; Lau et al., 2000). 
However, one recent study reported increased risk of asthma in 6-year-old children exposed to 
cat allergens early in life, but no association was seen for mite allergen (Torrent et al., 2007). 
On the other hand, early-life exposure to high mite allergen levels appears to increase the risk 
of asthma development in high-risk children (Almqvist et al., 2003; Brussee et al., 2005; 
Celedon et al., 2007).  
Exposure to pet and HDM allergens may also increase the risk of rhinitis. However, 
although rhinitis and asthma often co-exist, and may be attributed to a common airways 
disease starting at the nose and including asthma (Lack, 2001; Leynaert et al., 2004), indoor 
allergens may exacerbate symptoms and increase BHR also in non-asthmatics with allergic 
rhinitis (Ciprandi et al., 2005). Moreover, even low allergen levels may induce symptoms in 
sensitized patients, as was shown by demonstrating nasal symptoms in patients challenged 
with concentrations of cat allergen (Fel d1) comparable to allergen levels in homes without 
cats (Bollinger et al., 1996). However, low allergen levels may also induce rhinitis symptoms 
in patients without detectable systemic IgE (Huggins and Brostoff, 1975) 
Other indoor allergens than cat, mite and dog allergens, which are usually included in 
the allergy test panels are mould and cockroach allergens. Although sensitization to airborne 
moulds has been related to the severity of asthma (Zureik et al., 2002), the link between 
indoor mould exposure as a risk factor for asthma development remains uncertain (Douwes 
and Pearce, 2003). Indoor mould exposure is uncommon in Norway, but for the few 
individuals that are exposed the effect on respiratory symptoms may be severe (Skorge et al., 
2005). Exposure to cockroach allergens has been found to exacerbate asthma in children 
living in the inner-city (Rosenstreich et al., 1997). In Norway, cockroaches are uncommon, 
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but sensitization to cockroach allergens has been found among the children in a family study 
on asthma genetics (Lodrup Carlsen et al., 2002).  
In contrast to HDM exposure that occurs in all habitats with a suitable environment, a 
susceptible individual may choose to try to avoid cat and dog allergen exposure by not 
keeping pets at home. Moreover, studies assessing pet keeping per se, rather than pet allergen 
levels, have reported pet keeping to increase, decrease or to have no effect on the risk of 
asthma development (Almqvist et al., 2003; Kerkhof et al., 2009; Sandin et al., 2004). 
However, pet avoidance is believed to be a confounding factor in studies on associations of 
exposure to pets and development of allergic disease (Eller et al., 2008), and suggested to 
account for the putative ‘protective’ effect of pet keeping observed in some studies (Almqvist
et al., 2003; Brunekreef et al., 1992). In addition to removing the allergen source, 
environmental control practices can also be performed to reduce the allergen exposure. There 
are several common recommendations for allergen avoidance, such as vacuuming, washing 
the bed linens and clothing regularly, and the use of air filters and dehumidifiers (Tovey, 
2008). However, these recommendations for reducing the allergen exposure may differ in 
their efficiency in regard to different sources of indoor allergens (Tovey, 2008).  
Allergic sensitization to cat and dog allergens are commonly observed in individuals 
who do not have pets at home (Chen et al., 2007; Perzanowski et al., 1999). In one study it 
was found that the prevalence of sensitization to pets was linked to the abundance of pets in 
the community (Braback et al., 2001). Since these allergens are easily bound to textiles 
(D'Amato et al., 1997) and human hair (Karlsson and Renstrom, 2005), pet allergen exposure 
in public areas may be dependent on the community prevalence of furry pets (Almqvist et al., 
1999; Instanes et al., 2005; Perzanowski et al., 1999). Children without pets at home may thus 
be exposed to higher allergen levels at kindergarten and school than at home (Almqvist et al., 
1999; Perzanowski et al., 1999).  
2.3.6 Endotoxins and ß(1,3)-glucans
Many microorganisms inherently possess adjuvant activity in the form of immunostimulatory 
molecules such as lipopolysaccharide (endotoxin) and muramyl dipeptide (Delves and Roitt, 
2000). Viable and nonviable parts of microorganisms are found in varying concentrations in 
many indoor and outdoor environments. Microbial exposures early in life are hypothesized to 
prevent allergic sensitization and asthma by promoting a Th1-type (non-allergic) immune 
development (Abraham et al., 2005; Holt and Jones, 2000). However, exposure to microbial 
components may also promote a Th2-type (allergenic) immune development. One possibility 
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is a gene-environment effect, as previously discussed (Bruce et al., 2009; Ege et al., 2007). 
Environmental exposure to microbial products may, therefore, have a crucial role in the 
development of a child’s immune response. 
Endotoxin is a component of the cell wall of all gram-negative bacteria, and is 
therefore ubiquitous in the environment. The paradox of endotoxin is that higher levels of 
exposure early in life may inhibit the development of allergy and asthma (Abraham et al., 
2005; Celedon et al., 2007; Douwes et al., 2006; Schram et al., 2005; von Mutius et al., 
2000), but exposure to high levels of endotoxin is also a frequent cause of asthma-like 
symptoms in a wide range of occupational settings such as cotton and textile processing, and 
livestock farming (Bakirci et al., 2007; Thorne et al., 2004). Asthmatics are particularly 
sensitive to inhaled endotoxin, and inhalation induces both immediate and sustained airflow 
obstruction (Michel et al., 1997; Rylander et al., 1989). These findings are in line with the 
reports on increased risk of wheezing in high-risk children exposed to endotoxin (Gillespie et
al., 2006; Park et al., 2001; Perzanowski et al., 2006). 
It is likely that other microbial agents, like mould components, may affect immune 
responses (Douwes et al., 2006). ß(1,3)-glucans, a cell wall constituents of most fungi, have 
strong immunomodulary effects (Novak and Vetvicka, 2008). ß(1,3)-glucans have been found 
to increase the IgE response to co-administrated allergen (adjuvant effect)  
(Instanes et al., 2004; Ormstad et al., 2000), but the susceptibility may differ between high- 
and low-risk children (Belanger et al., 2003). Nevertheless, the evidence of a causal role for 
ß(1,3)-glucan in allergic disease development is still very limited (Douwes, 2005). 
ß(1,3)-glucans have also been suggested as an indicator of moulds in the indoor 
environment, making it difficult to determine whether it is ß(1,3)-glucans itself, the mould 
exposure or other concomitant exposures such as from wet materials that are actually 
responsible for the observed effects in epidemiological studies (Rylander et al., 1998). ß(1,3)-
glucans can also derive from some bacteria and several higher and lower plants, and are 
therefore an uncertain bio-marker of mould exposure (Douwes et al., 1999). Similar problems 
may occur as the presence of pets, and also vermins such as mice and cockroaches (Bischof et 
al., 2002; Heinrich et al., 2001) are suggested to be important determinants of endotoxin 
(Bischof et al., 2002; Gehring et al., 2004; Giovannangelo et al., 2007; Heinrich et al., 2001) 
and ß(1,3)-glucans levels in house dust (Gehring et al., 2001). In addition, both higher ß(1,3)-
glucan and endotoxin levels are associated with floor carpeting, the number of individuals in 
the home, and lower frequency of vacuum and dust cleaning (Bischof et al., 2002; Gehring et
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al., 2001). However, these are factors that are also likely to be associated with elevated levels 
of cat, dog and HDM allergens. 
2.4 Epidemiological methods
2.4.1 Study designs
The objectives of epidemiological studies are to monitor the extent and the natural history and 
prognosis of a disease, and identify causes and risk factors that may lead to new preventive 
and therapeutic strategies (Gordis, 2000). Epidemiology is an extensive field and the 
following discussion will be focused on the use of epidemiology to identify factors implicated 
in disease onset.  
The most commonly used study designs to identify associations between exposure and 
disease in environmental epidemiology are cohort and case-control studies. In prospective 
cohort studies the population is identified at the start of the study. Exposure and non-exposure 
are ascertained as they occur during the study until the point when disease develops or not 
(Gordis, 2000). Depending on the outcome of interest, it may take many years to conduct such 
a study. An alternative approach is to perform a retrospective cohort study (a historical 
cohort). The exposure is ascertained from past records and outcome (disease) is recorded at 
the beginning of the study. However, the term retrospective has often been incorrectly used 
for case-control studies, as the term suggests that calendar time is the characteristic that 
distinguishes case-control from cohort designs. What distinguishes the two study designs is 
whether the study begins with diseased and non-diseased people (case-control study) or with 
exposed and non-exposed people (cohort study). A nested case-control study is a hybrid 
design in which a case-control study is established within a cohort study. 
In cross-sectional studies both exposure and disease outcome are determined 
simultaneously. But a cross-sectional study may also be retrospective in regard to the 
exposure.  
Cohort studies are usually preferred when the goal is to detect associations between 
exposure and disease development, but differences in design such as population-based, high-
risk (children with atopic parents) and enriched cohorts (a higher prevalence of high-risk 
children than in a normal population) and different follow-up time between exposure and 
disease may lead to heterogeneity in the observed associations.  
Although epidemiological studies have the advantage of real-life exposure situations 
and may accumulate information on exposure-response relationships, experimental (animal) 
models and in vitro studies are usually necessary to prove cause-effect relationship. However, 
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epidemiological studies can find associations between exposure and disease, but do not prove 
any cause-effect relationships. Intervention studies may support causal relationships between 
exposure and disease, because there is a certain control of the exposure. Moreover, 
epidemiological studies showing dose-response relationships may also give convincing 
evidence of causal relationship, such as between male lung cancer and the number of daily 
cigarettes smoked during the 10 years preceding the onset of the illness (Doll and Hill, 1952). 
Furthermore, accumulated information on exposure-response associations provided by 
epidemiological studies may in some cases lead to the identification of cause-effect 
relationships.  
2.4.2 Issues of concern
Important issues leading to the lack of ascertainment of causality in epidemiological studies 
are the problems of confounding, bias and interactions and stating temporality (Gordis, 2000).  
A confounder is an additional variable which may mask or distort the apparent effect 
of the exposure on the disease (Gordis, 2000). Typical confounders are age and gender. 
However, depending on the research question, gender could also be an important explanatory 
factor on its own. 
Interaction is a real difference in the effect of exposure in various subgroups, in which 
the effect of one variable depends on the value of another (Gordis, 2000). A typical example 
is smoking and asbestos which both lead to lung cancer, but where the effect of both 
exposures simultaneously is multiplicative and not additive to the risk of lung-cancer. 
Confounders and interactions are usually dealt with by statistical methods, typically by 
applying multivariate models to control for perceived or established confounders and 
interactions. If an interaction is confirmed, the data can also be stratified by the variable 
responsible for the interaction effect.  
Bias is any systematic error in the design, conduct or analysis of a study that results in 
an incorrect estimate of the association between the exposure and the disease (Gordis, 2000). 
Well-known examples of bias are selection bias, which is an important problem in case-
control studies, such as inclusion of hospital cases that may represent the more severe cases of 
disease. Participation bias may occur in cohort studies if the individuals who do not 
participate differ from those who do, in regard to socio-economic, cultural, life-style and 
medical characteristics. Selection and participation bias affect the possibility to generalise the 
finding because the participants do not represent the population of interest. Information and in 
particular recall bias are of major concern in retrospective study designs. Limitations in recall 
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may occur if the interviewed subjects do not recall or simply do not have the information 
being requested. In addition, recall bias occur when individuals with a disease remember their 
history of either or both disease and exposure better than individuals without disease. This 
was demonstrated in the German MAS study, where the parents showed improved recall of 
their own asthma and hay-fever symptoms after their child had developed allergic symptoms 
(Kulig et al., 2000). However, if all subjects are affected randomly, no bias is introduced. 
The temporality condition requires that the exposure has to precede the outcome, 
which is an undisputable factor when trying to establish causality. If the researcher has to go 
back in time to collect information on exposure and onset of disease (retrospective studies), 
the temporal link between exposure and disease may be unclear. In prospective cohort studies 
the temporality criterion is usually fulfilled as the observation period starts with exposed and 
un-exposed individuals before the disease (outcome) occurs.  
Nevertheless, epidemiology has the advantage of a real-life exposure situation. This is 
important since the effect of a complex mixture of environmental agents may be different than 
the sum of the effects of the individual components. In addition, the exposure concentrations 
reflect the actual range of human exposure. 
In view of the unanswered questions related to onset of allergic disease in childhood, the 
prospective birth cohort the Environment and Childhood Asthma Study in Oslo has the 
propensity to answer some of the environmental, genetic and life-style factors implicated in 
disease development. 
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3 Aims of the study 
 
The overall objective was to obtain more knowledge about the association between exposure 
to allergens and microbial factors in the indoor environment and the development of allergic 
diseases in childhood. In this context, the term ‘allergic diseases’, refers to allergy-related 
diseases with and without demonstrated allergic sensitization. 
 
The specific questions we sought to answer were: 
 
1. Is pet exposure influenced by a family history of allergic disease?   
2. Is exposure to furred pets associated with development of allergic diseases?  
3. Does exposure to house dust mite and microbial components influence the 
development of allergic diseases?  
4. Do boys and girls differ with respect to exposure and in exposure-disease 
associations?  
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4 Subjects and methods 
4.1 Study design
The present thesis is based on results from the prospective birth cohort the Environment and 
Childhood Asthma Study. The ECA study was established in 1992 as a collaborative study 
between Ullevål Hospital and the Norwegian Institute of Public Health. One of the main aims 
of the ECA study was to investigate associations between possible environmental risk factors 
and the development of childhood asthma. At the maternity wards of the two municipal 
hospitals in Oslo (Ullevål Hospital and Aker Hospital) 3754 infants (75% of all eligible) 
(Nafstad et al., 1996) were recruited at birth during 15 months from January 1st 1992. 
The infants were recruited on the following the criteria: 
 
Inclusion criteria:  
 Birth weight more than 2000 g. 
 Absence of any illness likely to impair respiration (severe respiratory, cardiovascular, 
neuromuscular or metabolic disease) 
 No requirement for assisted ventilation or oxygen therapy beyond 6 hours after birth 
Exclusion criteria: 
 Plans to move out of Oslo the next six months 
 Insufficient language comprehension by the parents to be able to complete 
questionnaires 
 
Lung function measurements (tidal flow-volume loops and passive respiratory mechanics) 
were performed shortly after birth (mean age (±SD): 2.7 (0.9) days) in 802 infants at the 
largest maternity ward at Ullevål Hospital (Lodrup Carlsen et al., 1994). The parents 
completed extensive questionnaires at birth and thereafter every sixth months for the first 2 
years of life. At 2 years of age, all the participating families were invited to submit dust 
samples from their home. 
A nested case-control study was established with cases identified by the questionnaires 
and clinical registration cards with doctors documenting signs of bronchial obstruction (BO) 
as well as direct referrals from well-baby clinics, hospital admissions and family doctors. A 
case was a child with recurrent BO (rBO) defined by at least two episodes of BO or BO 
lasting more than four months before 2 years of age. At least one episode of BO had to be 
confirmed by a doctor. The controls were children without BO born closest in time to the 
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case. The children (n=562) attended study follow-up investigations 1-2 times by 2 years of 
age.  
At 10 years, all the children who had attended at least one of the clinical visits the first 
2 years of life and/or had lung function measurements at birth were invited to a follow-up 
study (figure 3). A total of 1019/1215 (84%) of the eligible children attended the two days of 
examination (within a week) including lung function assessment, testing of bronchial 
hyperresponsiveness, exercise test by treadmill running, skin prick tests, collection of blood 
and urine samples, collection of parent-collected dust from the child’s mattress and an 
extensive interview of the parents performed by the study doctors.  
 
Lung function
n=802
Papers I and III (all 1019)
Paper II (n=260)
Paper IV (n=797)
2 years
10 years
Birth
n=616
n=140
Follow-up, n=1019/1215* (84%)
Recruited, n=3754
Case-control, n=562
Included in papers I-IV:
 
 
Figure 3: Simplified study design of the ECA study, and number of participants included in Papers I-IV. *Invited
children were all traceable children with either lung function measured at birth (n=802) and/or included in the
case-control group at 2 years (n=562), in total 1215.
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4.2 Subjects 
Papers I and III 
The study population of Papers I and III include all 1019 children (551 boys, 468 girls) who 
attended the 10-year follow-up study (mean age (± SD): 10.8 (0.83) years). The 1019 
participating children were at birth comparable to the 2735 non-included children with regard 
to gender, parental education, type of housing and parental smoking and pet keeping. 
However, due to the nested case-control study, the population was enriched with allergic 
disease, with significantly more parents or siblings having rhinoconjunctivitis (31.7%, vs. 
26.9% p = 0.004) and asthma (17.7% vs. 14.8%, p = 0.031). 
Paper II 
The study population of Paper II includes 260 (131 boys, 129 girls) of the 616 children 
attending the 10-year follow-up, who had lung function measured at birth and an available 
dust sample from 2 years of age. Except higher parental education level, they were similar to 
the 365 children without dust samples in regard to birth characteristics and pet keeping during 
the first 2 years of life. At 10 years of age, the 260 included children were less often 
sensitized to cat, but were otherwise comparable to the non-included children (10.4% and 
16.9%, respectively, P=0.02). 
 
Paper IV 
Paper IV includes the 797 of the 1019 children (437 boys, 369 girls) with an available dust 
sample from 10 years of age. At 10 years of age included children had less cats at home (18% 
vs 26%, p=0.007), less parents who smoked (38% vs 47%, p=0.02) and parents with a higher 
education than the 222 non-included children (without dust samples). They were otherwise 
comparable in regard to the children’s and the parents’ allergic disease, family income, type 
of housing, other pets than cats, and reported pet avoidance. 
4.3 Methods
4.3.1 Questionnaires and clinical examinations 
Parental questionnaire and interview
The semi-annual questionnaires during the first 2 years of life included questions about 
symptoms of respiratory and other allergic diseases in the index child, allergic diseases in 
parents and siblings, socio-economic status (parental education, income and housing etc.) and 
indoor environmental exposures like pet keeping, dampness, and parental smoking. 
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At the 10 year follow-up the parents responded to a structured interview completed by the 
study doctor, including core ISAAC questions about symptoms of lower and upper respiratory 
diseases, having a doctor’s diagnosis of asthma, reported doctor confirmed allergic 
sensitization, allergic diseases in parents and siblings, socioeconomic factors, pet keeping and 
pet avoidance, as well as other detailed questions regarding home environmental factors. 
 
Lung function measurements
Lung function measurements were performed at a mean age of 2.7 days after birth with tidal 
flow volume loops and passive respiratory mechanics by the SensorMedics 2600 system 
(Yorba Linda, Anaheim, USA), as described in detail elsewhere (Lodrup Carlsen et al., 1994).  
At 10 years of age lung function was measured by forced expiratory flow volume 
loops according to European standards (Quanjer et al., 1993) on a Sensor Medics Vmax 20c 
instrument (SensorMedics Diagnostics, Yorba Linda, CA, USA) on two occasions within a 
week. The reported values were the best values obtained of these two efforts and included 
forced expiratory volume in one second (FEV1) and forced expiratory flow at 50% of forced 
vital capacity (FEF50) as percent predicted [reference values of healthy 10-year old children 
from the ECA-study obtained by methods described by Stanojevic et al. (Stanojevic et al., 
2009)].  
 
Assessment of bronchial hyperresponsiveness 
At 10 years of age airway bronchial hyperresponsiveness (BHR) was assessed by both a direct 
method (methacholine challenge test) and indirect method (exercise challenge). Both tests 
were performed on separate days within the same week. The methacholine challenge test was 
performed according to international guidelines (Crapo et al., 2000) by inhaling doubling 
doses of methacholine nebulized by the inhalation triggered Spira Dosimeter (Spira 
Respiratory Care Center Ltd, Hämeenlinna, Finland) until a fall in FEV1 of 20% from the 
(post-saline) baseline value or until the maximum dose of methacholine (22.4 μmol) was 
reached. The exercise challenge test was performed by a 6-8 minutes treadmill run according 
to a standardized protocol (Carlsen et al., 2000) and lung function was measured before and 3, 
6, 10, 15 and 20 minutes after the test. 
Skin prick tests and specific IgE at 10 years of age 
Skin prick testing were performed according to the European standards (Dreborg and Frew, 
1993) with the following standardized allergen extracts from ALK (Soluprick®, ALK-Abello, 
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Denmark): Domestic mites (Dematophagoides pteronyssinus and D. farinae), German 
cockroach, dog, cat and rabbit allergens, birch, timothy (grass) and mugwort pollen, moulds 
(Cladosporium and Alternaria), egg white, milk, peanut and codfish. SPT were considered 
positive with a wheal diameter at least 3 mm larger than the negative control (saline). 
Total and specific serum IgE (IgE and sIgE, respectively) were analysed with a 
radioallergosorbent fluorescence immunoassay (ImmunoCAP® system, Phadia, Uppsala, 
Sweden). Specific IgE was analysed with the same panel of allergens as for SPT as well as the 
panel test “Phadiatop”, and considered increased with sIgE 0.35 kU/L.  
4.3.2 Collection and extraction of dust samples
Paper II 
The dust samples were collected by the parents according to detailed written instructions. 
They were asked to use new vacuum cleaner bags, vacuum the floor of the living area of the 
house and collect the entire sample of dust from the bags. The dust samples were shipped in 
plastic bags to the Norwegian Institute of Public Health and stored at -20°C until extraction 
and analysis. Endotoxin, allergens and ß(1,3)-glucans were extracted sequentially from un-
sieved dust by methods adopted from the Institute for Risk Assessment Science at University 
of Utrecht, the Netherlands (Schram et al., 2005). In short, endotoxin was extracted in 
pyrogen-free water with 0.05% Tween-20. The volume varied according to the net weight of 
the dust. After removal of supernatant for endotoxin analyses, the remaining dust pellet was 
re-suspended into phosphate-buffered saline with 0.05% Tween-20 (PBT) for allergen 
extraction. Finally, the pellet was re-suspended and autoclaved at 120°C for ß(1,3)-glucans 
extraction. The samples were stored at -20ºC until analysis. 
 
Paper IV 
Dust from the child’s bed mattress was collected by the parents with vacuum cleaners 
equipped with a special dust collector (P-B Miljø A/S, Bjerringbro, Denmark) (Dreborg et al., 
1995). The families were urged not to change bed linen for one week prior to the sampling of 
the mattress dust. The families were instructed to vacuum the mattress for four minutes, and 
to report the size of the mattress and the effect of the vacuum cleaner. At the laboratory, the 
dust was vacuumed (sieved) through a filter with pore size 0.3 μm, and the fine fraction of the 
dust was weighed and extracted in phosphate-buffered saline with 0.02% NaN3 and agitation 
at room temperature overnight. The supernatant was the stored at -20ºC until analysis.  
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4.3.3 Analyses of allergens, endotoxin and ß(1,3)-glucans in dust 
samples
In Papers II and IV the concentration of cat (Felis domesticus, Fel d1), dog (Canis familiaris, 
Can f1) and house dust mite (Dermatophagoides pteronyssinus, Der p1) allergens were 
determined by enzyme-linked immunosorbent assay (ELISA) following the manufacturer’s 
instructions (Indoor Biotechnologies, Clewyd, UK) (Chapman et al., 1987). Concentrations 
were expressed as μg allergen per gram dust. 
Endotoxin (Paper II) was analyzed with the kinetic chromogenic Limulus Amebocyte 
Lysate (LAL) test, using the same batch of LAL reagents and standards for all analyses 
(BioWhittaker, Walkersville, USA, LAL lysate lot no. FL119G, Lipopolysaccharides (LPS) 
standard lot no. FL0835). Thirty percent of the samples were tested in duplicate, with a mean 
coefficient of variation of 4.8%. Concentration was expressed as endotoxin units (EU) per 
milligram dust. 
ß(1,3)-glucans (Paper II) were measured with an inhibition enzyme immuno assay 
(EIA) (Douwes et al., 1996) with affinity-purified anti-ß(1,3)-glucan antibodies (Batch 9819, 
provided by Dr. G. Doekes, IRAS, Utrecht, The Netherlands). The concentration was 
expressed as μg ß(1,3)-glucan per gram dust.  
The extractions and analysing procedures are described more thoroughly in the 
individual papers. 
4.3.4 Definitions and outcomes at 10 years
BHR was defined as PD20 methacholine 8 μmol in Paper II and separated into BHR (PD20 8 
μmol) and severe BHR (PD20 1 μmol) in Paper III. BHR was reported as a continuous 
variable with the methacholine dose-response slope (DRS) calculated from each individual 
(per cent decline in FEV1 after the final dose of methacholine divided by the cumulative dose 
of methacholine inhaled (O'Connor et al., 1987)) in Papers III and IV. 
The exercise test (Papers III and for defining current asthma) was considered positive 
for exercise-induced bronchoconstriction (EIB) with a fall in FEV110% of baseline FEV1 
measured 3-20 minutes after running ceased. 
A history of asthma (Paper II) was defined in children by the presence of at least two 
of the three criteria; asthma symptoms, doctor’s diagnosis of asthma, and use of asthma 
medication (Lodrup Carlsen et al., 2006a). 
Current asthma (Papers II - IV) at 10 years of age was established when a child with a 
history of asthma had either had symptoms or used asthma medication within the last 12 
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months and/or had a positive exercise challenge test at the 10 year follow-up visit (Lodrup 
Carlsen et al., 2006a). 
Allergic sensitization (Paper II) was defined by at least one positive SPT and/or sIgE 
to any of the allergens tested.  
Current rhinitis (Papers III and IV) was present in a child reporting at least one of the 
following symptoms (without a cold) during the last 12 months: runny nose, blocked nose, or 
sneezing. Conjuntivitis required a report of itchy/runny eyes during the last 12 months. Other 
outcomes related to rhinitis (Papers III and IV) were retrieved from the parental interview at 
10 years of age, and are presented in table 1.  
Current rhinitis with allergic sensitization (Papers III and IV) was defined in a child 
with current rhinitis combined with at least one positive SPT and/or sIgE to any of the
inhalant allergens tested: seasonal (pollens or moulds) or perennial (house dust mites, cat, 
dog, rabbit or cockroach). Mixed sensitization was defined with SPT/IgE positive to at least 
one seasonal and one perennial allergen. 
Current wheeze (Papers III and IV), and otitis media and atopic eczema (Paper III) 
were defined by the presence of these outcomes (as reported by the parent in the interview) 
during the last 12 months. 
Variables regarding pet keeping (Papers I, II and IV), pet avoidance, socioeconomic 
factors, and atopic disease were retrieved from questionnaires and interview and are presented 
in table 2.  
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Table 1 Questions related to symptoms, triggers and medical treatment of rhinitis from the structured 
parental interview at the 10-year follow-up [the questions are translated from Norwegian (Appendix
B)]
INTERVIEW QUESTIONS OUTCOMES
Has the child had any of the following symptoms 
during the last 12 months (without a cold): a) 
runny nose, b) blocked nose, c) sneezing, d) 
itchy/runny eyes 
Rhinitis (a, b and/or c) 
Conjunctivitis (d) 
What causes the eye/nose symptoms? a) not 
known b) dog c) oat d) other furry pets e) other 
causes f) pollen from trees g) other pollens h) 
temperature changes/physical activity 
Unknown cause of symptoms (a) 
Symptoms related to furry pets (b,c, d) 
Symptoms related to pollens (f, g) 
Symptoms related to furry pets and pollens (b, c 
d and b, c) 
Symptoms related to other causes than allergens 
(e, h) 
 
Does the child have symptoms of rhinitis during 
a) the whole year, b) spring/summer or c) 
autumn/winter 
Time of year when symptoms occur 
How much impact have these symptoms had on 
daily life activities? a) none b) some c) moderate 
d) severe   
Impact on daily activities  
Has the child ever been given the diagnosis 
hayfever/allergic rhinitis? 
Doctor diagnosed hayfever ever  
What kind of treatment has the child received due 
to symptoms of rhinitis? a) none b) don’t know c) 
topical antihistamines d) systemic antihistamines 
e) topical cortocisteroids f) systemic 
cortocisteroids g)sodium cromoglycateh) 
leukotriene antagonist i) immunotherapy j) 
homeopathy k) other alternative medicine 
Received medical treatment due to rhinitis (b-i) 
Alternative medicine (j-k) 
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Table 2 Questions concerning  allergic disease, socio-economic factors and pet-keeping from 
questionnaires at birth till 2 years of age  and from parental interview at the 10-year follow-up 
[translated from Norwegian (Appendix A and B)]
AGE QUESTIONS OUTCOME
Allergic disease in the index child and child’s family  
6, 12, 18 and 
24 months 
Has the child had atopic eczema during the last 6 
months? 
Atopic eczema by age 2 
 
Has the child ever had any of the following symptoms 
irrespective of a cold: runny nose, blocked nose, sneezing 
and/or itching/runny eyes? 
Has the child ever had any allergies confirmed by a 
doctor? (not including food-allergies) 
 
 
Allergic rhinoconjunctivitis ever 
Has the child ever had a diagnosis of asthma confirmed 
by a doctor? 
Ever diagnosed with asthma  
 
 
 
 
10 years 
 
 
 Has the child previously experienced respiratory 
(wheezing) symptoms caused by furry pets? 
Wheezing symptoms due to furry 
pets 
Have any of the following family members ever had 
asthma: Father, mother or siblings?   
Siblings or parents with a history 
of asthma 
 
Birth  
 Have any of the following family members ever had 
rhinoconjunctivitis: Father, mother or siblings?   
Siblings or parents with a history 
of rhinoconjunctivitis 
Environmental and socio-economic factors
What was the total family gross income last year?  
1:<100, 2:100-199, 3:200-299, 4:300-500,5:>500  in 
1000 NOK 
Family income  
 
 
 
Birth 
 Do mother and/or father smoke at home (sometimes or 
daily)? 
Parental smoking at birth 
10 years Did mother and/or father smoke at home a) before 
school-age (age 6-7) b) after school-age 
Parental smoking (after child’s 
birth) 
Birth and 10 
years 
Which type of house does the child live in?  
a) flat b) detached/semi-detached house. 
Housing 
 
Birth Father and mother highest completed education: a) 
compulsory (± 1-2 year county college) b) college c) 
university 
Parents’ education (highest 
education by either parent) 
With whom does the child live with more than >50% of 
the time? a) mother and father b) mother c) father 
Single parenthood   
10 years 
Has the family avoided pets or removed pets due to 
allergy in the family and/or to prevent the child from 
developing allergies? 
Reported pet avoidance 
Birth, 
6,12,18,24 
months and 
10 years 
Do you keep furry pets at home? If yes: a) cat b) dog c) 
other types of furry pets (rodents) 
Cats, dogs or other furry pets at 
birth 
Change in pet ownership from 
birth to age 10 
10 years Did you keep cats, dogs or other furry pets at home 
during the child’s first year of life? 
Retrospective information on pet 
keeping during first year of life  
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4.4 Statistical methods
Categorical variables were compared by Pearson’s chi-square test or Fisher’s exact test when 
small cell numbers. Differences in continuous variables between multiple groups were 
assessed by one-way ANOVA (Paper IV), or by the nonparametric Mann-Whitney U test, and 
correlations were given by Spearman’s rho () coefficient (Paper II). Log-transformed 
categorical variables were presented as geometric mean (GM) and 95% confidence intervals 
(95% CI). 
The procedure used for the multivariate logistic regression models in Papers I and II 
was backward elimination technique, starting with all the candidate variables in the model 
(Hosmer D.W. and Lemeshow S, 2000). All the predictor variables had equal entry status in 
the models. At each step, the variable that was the least significant was manually removed. 
This process continued until only statistically significant variables remained in the model. The 
condition of linearity of the continuous variables in Papers II and IV was tested with a 
fractional polynomial analysis (Sauerbrei and Royston, 2009) which supported treating the cat 
and dog allergens, endotoxin and ß(1,3)-glucans variables as continuous and linear in the 
models. For the linear regression models in Paper II, the condition of normally distributed 
residuals of the dependent variable was fulfilled. In Paper IV, a linear regression with DRS as 
outcome variable was performed. DRS was log-transformed due to the highly skewed 
distribution of the variable, and due to the violation of normality and homoscedasticity 
assumptions, a robust regression was performed, using Huber’s method (Hamilton, 1991). 
The values resulting from the linear regression model were back-transformed and the results 
presented per increase in DRS. Furthermore, all multivariate models were tested for 
confounding and interactions. 
The limit of statistical significance was set to 0.05 (5%). Statistical analyses were 
performed with Statistical Package for Social Sciences (SPSS version 14.0, SPSS Inc., 
Chicago, Illinois, USA) and Statistical Analysis System (SAS version 9.1.3, SAS Institute 
Cary, NC, USA) and Number Cruncher Statistical System (NCSS version 2007, Kaysville, 
Utah). 
 
Categorization of lung function (Paper II)
tPTEF/tE and VE (expiratory volume) from the lung function measurements at birth were 
dichotomized according to the median value of 0.29 and 24.2, respectively. For calculation of 
change in lung function from birth (tPTEF/tE) to age 10 (FEV1 or FEF50), z-scores based upon 
mean and SD of the healthy subjects were calculated. The z-scores describe each child’s 
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position relative to the healthy individuals in the population. The reference value for the z-
scores at birth were calculated for all children (as they were healthy at the time) and at 10 
years for all children without any lower respiratory tract infections during the first 2 years of 
life and without a history of asthma (Haland et al., 2009). 
 
Prevalence of rhinitis (Paper III)
To adjust for the enrichment of children with bronchial obstruction during the first 2 years of 
life, an overall prevalence of rhinitis was calculated by the weighted mean of the prevalence 
of rhinitis for the following groups: i) rBO by age two, ii) controls, and iii) the children with 
lung-function measured at birth who were not included in the case-control group. The rhinitis 
prevalence for these three groups was calculated for girls and boys separately and the weight 
was the number of children in each group. The prevalence was reported with confidence 
intervals. 
4.5 Ethical issues
Written informed consent was obtained from parents of all the included infants at the 
maternity ward before inclusion in the ECA study. Renewal of the consent was obtained at 
enrolment into the 10 year follow-up study after written information to the parents as well as 
the child. The study was approved by the Norwegian Data Inspectorate and the Committee for 
Medical and Health Research made no objections to the study. The study is registered in the 
Norwegian Biobank Registry.  
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5 Results
5.1 Pet exposure and family history of allergic disease
At birth, 7.9% and 9.3% of the 1019 families had cats and dogs, respectively. Pet ownership 
was more common at 10 years of age at which time, 19.8% of the families reported having 
cats and 15.2% having dogs. The biggest change was seen for furry pets (rodents) other than 
cats and dogs from 1.3% at birth up to 17.9% at the age of 10. Overall, 319 families reported 
pet avoidance, of which 70% had never kept pets, 8% had given up pets, and 22% had a least 
one furry pet at the time of the follow-up (Paper I). Of the 215 families keeping furry pets 
during the child’s first year of life according to questionnaires at birth, 6 and 12 months, 24% 
failed to report these pets at the 10-year follow-up. 
The parents’ and siblings’ history of asthma and rhinoconjunctivitis did not show a 
statistically significant association with pet keeping at birth, with pet removal or with pet 
acquisition at 10 years of age. Nor was pet removal or pet acquisition related to early 
symptoms of rBO or a doctor’s diagnosis of asthma in the index child (Paper I). However, 
acquisition of cats and dogs after birth was less likely if the index child had allergic 
rhinoconjunctivitis ever confirmed by a doctor. Also at 10 years of age, children with current 
rhinitis and/or allergic sensitization had significantly lower cat and dog allergen levels in their 
mattress dust compared to children without current rhinitis and allergic sensitization (Paper 
IV).  In the multivariate analysis, reported pet avoidance, but not cat and dog allergen levels 
in mattress dust, was significantly associated with current rhinitis. The majority of children 
with allergic sensitization at the 10-year follow-up study were already aware of their 
sensitization status, as 90% reported a previously confirmed doctor’s diagnosis of allergy to 
inhalant allergens (Paper IV).  
Socioeconomic factors like single parenthood, smoking and education level were also 
strong determinants of pet keeping (Paper I). Parental smoking was associated with cat 
keeping at the child’s birth as well as with acquisition of cats and/or dogs later in childhood. 
Children living with a single parent (n=246) by the age of 10 years (78% single mothers) were 
more likely to have acquired cats, but also to have removed their dog. On the other hand, high 
parental education was associated with both reported pet avoidance and with not having dogs 
at the time of the child’s birth.  
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5.2 Pet exposure and allergic disease 
Overall, 34.4% of the children were sensitized to at least one inhalant allergen at 10 years of 
age, and 17.8% were sensitized to both seasonal and perennial allergens (Paper III). Timothy 
grass, birch, dog, cat and mugwort were the most prevalent sensitizing inhalant allergens 
(Figure 4). Twenty-five per cent of the 1019 children attending the 10-year follow-up had 
current rhinitis (n=254), and 72.8% of these were sensitized to at least one allergen. 
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Figure 4: Grey bars represents the number of children with sensitization to each of the specific
allergens in increasing order from the most common (timothy grass) to the least common 
(Cladosporium), and the black fields of the bars represents the number of children with mono-
sensitization. The dots represent the number of children for each specific sensitizing allergen who
also have current rhinitis.
 
The majority of children (193/254) reported allergen-triggered rhinitis, of whom 15 children 
reported symptoms triggered by furry pets only, 53 by pollen and furry pets, and 125 by 
pollen only. Children with symptoms related both to pollen and furry pets more frequently 
had co-morbidities of asthma and wheeze and more severe BHR (PD201) than children with 
pollen-triggered rhinitis only (all p0.01). However, among the children who had become 
sensitized at the 10-year follow-up, 50.4% of those who reported pollens as the only trigger of 
rhinitis, were in fact sensitized also to non-seasonal allergens (mostly to cat (37%) and/or dog 
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(24%)), whereas 28.8% were sensitized to seasonal allergens alone. Notably, 18.4% of the 
children with reported pollen-triggered rhinitis had no allergic sensitization (Paper III).  
The children who were unable to relate their symptoms to any specific triggers had 
significantly higher dog allergen concentrations in their mattress dust (GM: 0.67 (95% CI: 
0.37, 1.22) μg/g dust) compared to the children with recognised perceived rhinitis triggers 
(0.34 (0.25, 0.46)), p=0.050 (adjusted for dog ownership) (Paper IV). However, assessing 
influence upon current rhinitis symptoms, impact the symptoms had on daily life activities, 
and perceived triggers of rhinitis, the multivariate analyses adjusted for gender, allergic 
sensitization, current asthma and reported pet avoidance, demonstrated no significant effect of 
the level of cat and dog allergens. 
Assessing the risk of allergic disease at 10 years of age by pet allergen exposure in early 
childhood demonstrated that only cat allergen levels were associated with later disease. Thus, 
the risk of current asthma at 10 years of age increased with an odds ratio of 1.20 (95% CI: 
1.01, 1.43), p=0.04, per 10 μg increase in cat allergen levels at 2 years of age (Paper II). 
However, stratifying by allergic sensitization, the association was significant only for children 
without allergic sensitization (adjusted OR: 1.32 (1.07, 1.62), p=0.009). Dog allergen levels at 
2 years of age, however, did not modify the risk of allergic disease at 10 years of age. 
Moreover, the children who were sensitized to cat and dog allergen at 10 years of age were 
most likely to never having kept cats (85%) and dogs (91%) at home (Paper II). 
5.3 The influence of house dust mite and microbial components on 
the development of allergic disease 
The levels of endotoxin and ß(1,3)-glucan at the age of 2 did not modify the risk of allergic 
sensitization, asthma, or BHR at 10 years of age (Paper II). Although FEV1 % predicted at 10 
years of age decreased with increasing levels of endotoxin in the home at 2 years of age, the 
effect was small and disappeared after removing one extreme outlier from the analyses. The 
levels of endotoxin and ß(1,3)-glucan measured in house dust at 2 years of age was not 
associated with pet keeping, and the correlations between cat and dog allergens, ß(1,3)-glucan 
and endotoxin were weak for all groups (all  0.17).  
Detection of HDM allergen, Der p1, was uncommon in the present study. Only 1.5% of 
the house dust samples from 2 years of age (Paper II) and 12.3% of the mattress dust samples 
from 10 years of age (Paper IV) had detectable levels of Der p1. Nevertheless, the 8.8% of the 
children who were sensitized to Der p1 at the age of 10, had significantly higher Der p1 levels 
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in their mattress dust compared to those without Der p1 sensitization, (GM: 0.21 μg/g dust 
(95% CI: 0.16, 0.28) and (0.16 μg/g dust (0.15, 0.17)), p=0.004, respectively (Paper IV).  
5.4 Gender effects on exposure and exposure-disease association
At 10 years of age boys were significantly more likely to have current asthma (p=0.002), 
current rhinitis (p=0.001) and to be sensitized to inhalant allergens (p<0.001) as compared to 
girls, whereas 10.1% of the girls and 7.4% of the boys had symptoms of rhinitis without 
detected allergic sensitization (p=0.3) (Paper IV). 
The predicted probability of asthma at 10 years of age related to cat allergen levels at 
home at 2 years of age (Paper II) was higher for boys than for girls (Figure 5).  
 
Figure 5: The predicted probability of current asthma at age 10 for boys and girls based on risk 
calculation (OR) in relation to  increase in cat allergen exposure at 2 years of age, adjusted for 
alcohol in pregnancy (reference:no), parental rhinoconjunctivitis at birth (reference:no) and parental
education (reference category 4: college, vocational).
 
 
Families in which the index child was a girl were more likely to acquire other furry pets than 
cats or dogs, compared to families with boys (adjusted OR: 1.85, 95% CI: 1.33, 2.56) (Paper 
I). At 10 years of age, girls tended to report more cats at home and regular contact with cats 
(p=0.03), but no significant gender difference was seen for dog contact or dog ownership 
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(p=0.4) (Paper IV). However, regardless of pet ownership, girls had higher levels of cat and 
dog allergens in their mattresses compared to boys (both p 0.001) (Paper IV).  
The association between cat and dog allergen levels in mattress dust and current 
rhinitis symptoms did not differ significantly between boys and girls, whereas HDM allergen 
levels interacted significantly with gender in relation to current rhinitis (Paper IV). The latter 
association was seen for girls only, where adjusted odds ratio of current rhinitis symptoms 
increased with 1.20 (95% CI: 1.01, 1.42) per 1 μg/g increase in HDM allergen levels 
(p=0.037). No significant association was seen for boys (p=0.9).  
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6 Methodological considerations
6.1 Dust sampling
Comparing allergen concentrations and microbial components measured in dust samples from 
different studies is challenging due to variation in sampling, storage and extraction 
procedures. As an example, HDM allergen is most common in mattresses, whereas the living 
room and kitchen may be more appropriate for endotoxin and ß(1,3)-glucan exposure 
assessment (Douwes et al., 1996; Hyvarinen et al., 2006). The dust samples from the homes 
of the 2-year-old children in the present study (Paper II) represent an overall exposure of the 
living areas in the house (living room, kitchen and bedrooms). Although this may be an 
appropriate surrogate marker for assessment of a child’s overall exposure in the home, 
restricting the sampling area to e.g. the living room or bedroom would probably have been a 
better sampling procedure for the present study. Furthermore, the surface type such as carpets 
vs smooth floor and the presence of dust reservoirs like sofas, pillows, and soft toys may 
affect the concentrations of allergens and microbial agents (Arbes et al., 2005; de Bilderling
et al., 2008).  
It is generally accepted that air sampling is the most representative method to assess an 
individual’s exposure to pet allergens by inhalation. However, the week-to-week variation of 
airborne Fel d1 (the major cat allergen) has been found to be substantial both in homes with 
and without cats due to varying degrees of disturbance by the humans and the cats (Bollinger
et al., 1996). Moreover, air sampling is time consuming and often impractical (because of 
noise). Settled dust is an attractive surrogate measure of personal exposure, in particular in 
epidemiological studies where the technique of measuring exposure must be simple, reliable, 
reproducible, and not time-consuming (Custovic et al., 1999). Preferably, dust samples should 
be collected by fieldworkers with standardized procedures. However, comparisons of dust 
collection applied by study subjects and fieldworkers show that collection by study subjects 
are reliable (Arbes et al., 2005; Schram-Bijkerk et al., 2006). This procedure represents a 
practical option for allergen and microbial agent exposure assessment, due to both high return 
rates and moderate to high correlation to the levels of biological components collected by the 
fieldworkers (Arbes et al., 2005; Schram-Bijkerk et al., 2006).  
Exposure to indoor moulds may vary by season due to outdoor variations in mould 
concentrations. Settled dust has also shown seasonal variation in levels of endotoxin 
(Hyvarinen et al., 2006), HDM and cat allergens (Gehring et al., 2001; Heinrich et al., 2003).  
In our studies (Papers II and IV) we did not adjust for seasonal variation. Nevertheless, the 
  43 
Methodological considerations 
___________________________________________________________________________ 
between-home variability due to housing type, pet ownership, and other household factors is 
usually greater than within-home variability in different seasons (Heinrich et al., 2003). 
Furthermore, repeated measurements of HDM allergen, cat allergen and endotoxin in settled 
house dust has been found to improve the estimate for annual mean concentrations. However, 
even a single observation of these biological contaminants may be a good proxy for the 
average annual exposure since repeated measures are usually highly correlated (Heinrich et 
al., 2003).  
For the mattress dust sampled at the 10-year follow-up, we found that the amount 
(weight) of dust depended on the power of the vacuum cleaner the parents had used to collect 
the dust (results not shown). It was therefore not feasible to present the concentrations as 
μg/m2, which instead was presented as μg/g dust. Using amounts of dust as a mean for 
hygiene (Gehring et al., 2001) or concentrations of allergens and microbial components per 
square meter is nevertheless not recommended unless the sampling is strictly standardized 
(Wickens et al., 2004). 
6.2 Extraction and analysis of allergens, endotoxins and ß(1,3)-
glucans
Dust samples may contain a broad spectrum of allergens, microbial agents and their 
components, proteolytic enzymes and other undefined substances. The dust samples are likely 
to vary in humidity depending on the conditions of the sampling locations. In un-frozen 
samples these factors could potentially lead to differences in post-sampling bacterial growth, 
but this is less likely to affect dust samples that are kept frozen until extraction and analysis, 
as was the case for the dust samples in the present study. The long storage time of the house 
dust samples (approximately 10 years) (Paper II) can potentially have affected the 
concentration of allergens and microbial components. Only Fel d1 (cat allergen) 
concentrations have been found to possibly decline with increasing storage time (up to 10 
months), whereas, Der p1 (HDM), endotoxin and ß(1,3)-glucans were unaffected by the 
duration of storage (Fahlbusch et al., 2003). Unfortunately, we do not know the effect of the 
storage time on our samples, but the levels of cat and dog allergens measured in homes with 
cat and dog keeping were significantly higher than in homes without these pets. However, it is 
mostly freeze-thaw cycles, and not the duration of storage that may affect the concentration 
levels (Douwes et al., 1995; Fahlbusch et al., 2003). All the samples in the present study have 
been treated in exactly the same way and have not been subjected to freeze-thawing cycles. 
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Also, the variation in allergen and microbial component levels between homes is probably 
much more pronounced than the potential influence of storage time (Fahlbusch et al., 2003). 
Unfortunately, we were not able to measure endotoxin and ß(1,3)-glucans in the 
mattress dust sampled at 10 years of age. These dust samples had been extracted for allergen 
analysis before the endotoxin and ß(1,3)-glucan extraction protocols had been established in 
our laboratory, and the extraction fluid was not endotoxin-free. The extraction of the floor 
dust samples (Paper II) for all analyses were performed by standardized protocols as 
established by the Institute for Risk Assessment Sciences (IRAS), Utrecht, the Netherlands 
(Schram-Bijkerk et al., 2005). According to the protocol, the floor dust samples (Paper II) 
were not sieved, whereas the dust samples from the mattresses (Paper IV) were sieved. 
Sieving of dust has the advantage of removing heavy particles such as sand which may affect 
the weight of the sample. Thus, it would have been more appropriate to sieve the floor dust 
and not necessarily the mattress dust.  
The conventional LAL assay that is used for endotoxin detection is not entirely 
specific for endotoxin and may give false-positive results with ß(1,3)-glucan (Vassallo and 
Limper, 1999; Zhang et al., 1994). In the present study (Paper II) we did not find any 
correlation between the concentrations of ß(1,3)-glucan and endotoxin, but the microbial 
components were nevertheless mutually adjusted for each other as they were both included in 
the same multivariate analyses.  
In the ELISAs used to measure the levels of allergens, the detection limits were 
determined according to the standard curve for each run. The levels below the detection limits 
were given a value of 2/3 of the detecting limit. For concentrations lying off the linear part of 
the standard curve, the assays were repeated with diluted samples. The results of the ELISA 
were given as the mean concentrations of the sample measured in two wells on the same plate, 
and a diluted sample may result in a poorer coefficient of variation between the wells 
compared to undiluted samples. Presenting variables in percentiles might mask the effect of 
the higher variability in the concentrations measured in diluted samples. However, the use of 
percentiles was not chosen because the resulting associations with health outcomes would 
then depend on the cut-off between the groups (see discussion of statistical methods below). 
Also, continuous variables will usually provide a better statistical power than using variables 
in categories. 
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6.3 Statistics 
In Paper I all the 1019 children followed up to 10 years of age were included in the analyses. 
In the nested case-control group at 2 years of age, the controls were included as children 
without bronchial obstruction (BO) born closest in time to children with rBO during the first 2 
years of life, and no other relevant matching was performed. However, analyses were not 
matched case-control analyses, as this would have lead to restricted sample-size for analyses. 
Although such analyses in general are optimal for subjects enrolled in a case-control study, 
the main aim of Paper I was to identify which factors could be important for pet avoidance 
and pet keeping without any a priori hypothesis of which variables this might be. Thus, all the 
predictor variables (including rBO or not) had the same ‘status’ in the multivariate models. 
In Paper II, an alternative approach for analysing allergens, endotoxin and ß(1,3)-
glucans would have been to categorize the exposure into groups using quartiles. Such an 
approach would, however, depend upon the cut-off value and important associations in the 
tail-ends (upper and lower) may be missed in the analyses. Moreover, using quartiles would 
only hamper the possibilities to compare ours with other results if different cut-off values are 
used. This is particularly important since our geographical area may have different overall 
levels of HDM allergens and endotoxin than found in other geographical areas and in rural 
communities. 
Variables that are highly skewed, which is typical for cat and dog allergen 
concentrations measured in house dust, are often log-transformed. This is appropriate when 
applying parametric statistical methods. However, in the logistic regression model, the 
variables can be used as continuous variables without log-transformation, as long as the 
criterion concerning linearity is fulfilled. In Paper II, the condition was tested according to a 
procedure suggested by Sauerbrei and Royston (Sauerbrei and Royston, 2009). We performed 
a fractional polynomial analysis that supported treating the bio-contaminant variables as 
continuous and linear in the model (as the best non-linear transformations were not 
significantly different from the linear model). For the linear regression models, the condition 
of normally distributed residuals of the dependent variable was fulfilled in the models of 
FEV1, FEF50 and change in lung function from birth to the age of 10 (Paper II). 
In Paper II, we included a figure illustrating the predictive probability of current 
asthma based on risk associations (OR) from the logistic regression analysis (Figure 5). The 
x-axis of cat allergen exposure includes exposure levels from 0-800 μg/g dust. The majority 
of the children (95%) in the present study were exposed to cat allergen levels (Fel d1) below 
100 μg/g dust. However, as the figure describes probabilities from 0 to 1, it will inevitably 
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include allergen levels that are above the levels that the children in the present study were 
exposed to at the age of 2 years.  
In Paper II, an increased risk of current asthma at 10 years of age was found in relation 
to increasing exposure to cat allergens expressed in units of 10 μg/g dust. We could have 
expressed the risk of asthma by exposure to cat allergens in units of 1 μg/gram dust. The 
corresponding increase in adjusted odds ratio of asthma by 10 years would be 0.12. Thus, the 
conclusions remain the same independent of using a unit of 1 or 10 μg allergen/g dust. A 
change in 1 μg allergen/g dust is likely to be introduced as a day-to-day variation, whereas a 
unit of 10 μg allergen/g may be a better measure of between-home variability, but may also 
illustrate a difference between homes with and without pets.  
The overall exposure to HDM allergen, Der p1, was in general low, and it was 
therefore more meaningful to use 1 μg as the unit of exposure for Der p1 (Paper IV). 
Furthermore, exposure levels measured in mattress dust are less prone to day-to-day variation 
and reporting the allergens in unit of 1 μg/g was therefore assumed to be more appropriate for 
the dust sampled from mattresses.
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7 General discussion
7.1 Pet exposure and family history of allergic disease
In the present study, pet avoidance appeared to be a strong confounder for rhinitis, in 
particular for the rhinitis children with allergic sensitization. The majority of the children 
(89.6%) who were sensitized to inhalant allergens at 10 years of age had previously received a 
doctor-diagnosis of allergy to inhalant allergens. It is likely that these children had been 
assessed for allergic sensitization status due to some allergy-related symptoms. Confirmed 
allergic sensitization to inhalant allergens may thus have prevented the families from 
acquiring pets.  
On the other hand, early asthma symptoms such as rBO during the first 2 years of life 
were not associated with reported or actual pet avoidance. Children with asthma-like 
symptoms early in life are at risk for developing asthma later in childhood (Martinez, 2009), 
as was found in the present cohort (Devulapalli et al., 2008). Furthermore, a doctor’s 
diagnosis of asthma (prior to the 10-year follow-up) did not influence the families’ decision 
on pet removal or pet acquisition. However, only 34.6% of these children reported doctor-
confirmed allergy to inhalant allergens, and avoiding pets may therefore not seem as 
important for ‘non-allergic’ types of asthma. However, the parents may not be aware of the 
risk of early asthma symptoms and ongoing allergic disease, or pet keeping may be more 
governed by social or emotional factors. Others have reported pet avoidance to be more likely 
for families of asthmatic children with rhinitis than for those without rhinitis (Hansel et al., 
2006), and that pet removal is commonly associated with disease development in the child 
(Bornehag et al., 2003; Brunekreef et al., 1992).  
In the present study, atopic eczema in the index child was association with removal of 
dogs after birth, whereas cat removal was not associated with allergic disease in the index 
child or the child’s family. Moreover, parental asthma and rhinoconjunctivitis was not 
associated with reduced pet keeping at the child’s birth, or with pet removal or acquisition of 
pets after birth. Similarly, a report from the Dunedin cohort from New Zealand, found that 
parents with or without a history of asthma or hay fever were equally likely to have cats or 
dogs at the child’s birth and to acquire cats or dogs during the first 9 years of life (Mandhane
et al., 2009).  
Further, in the present study, only 3.4% of the children reported wheezing symptoms 
by contact with pets prior to the 10-year follow-up. However, at 10 years of age, 25% of the 
children suffered from current rhinitis, and these children were often allergically sensitized 
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and suffered from allergy-related co-morbidities including asthma, atopic eczema and 
conjunctivitis. Thus, pet removal may be more common with advancing age in this cohort 
since it is expected that more children will develop allergic disease or experience worsening 
of their symptoms. However, several studies have found that patients with asthma may rather 
take asthma medication to control their asthma, than getting rid of a beloved pet (Hansel et 
al., 2006; Svanes et al., 2006). This has also been observed for patients diagnosed with 
allergy to dogs or cats (Coren, 1997). Svanes et al. (2006) reported that families with 
asthmatic parents refrained from getting rid of the pet even when their child got asthma. On 
the other hand, pet acquisition was less common among subjects with asthma in the ECHRS 
study (Svanes et al., 2006). 
The families in the present cohort acquired other furry pets than cats or dogs 
regardless of allergic disease in any of the family members. Rodents may be perceived as 
being less allergenic than cats and dogs. Furthermore, it may also reflect the children’s wish 
for pets as the gender of the index child (girl) and having older siblings were the strongest 
determinants for acquisition of other furry pets than cats or dogs.  
At the time of the child’s birth, only parental smoking and educational level were 
significantly associated with cat and dog keeping, respectively. Furthermore, smoking was 
associated with both cat and dog acquisition after birth. The associations between pet keeping 
and smoking as well as with a low parental education level have also been reported from the 
PIAMA birth cohort (Prevention and Incidence of Asthma and Mite Allergy) (Kerkhof et al., 
2009). Moreover, in the present study, single parenthood (n=246 with 78% single mothers) 
was associated with cat acquisition after the child’s birth. Thus, it appears that factors 
associated with socio-economic status may be important predictors for pet ownership.  
In the present study, the dog allergen levels in mattress dust at 10 years of age was 
lower for children with than without allergic sensitization, even though dog ownership was 
similar in the two groups. This could be due to a stronger effort to reduce the allergen load in 
families of sensitized children. Thus, avoidance may not only affect pet ownership, but also 
be expressed as allergen avoidance. Vacuuming is a common recommendation for allergen 
avoidance, but appears to have only minor effects on allergen removal (Tovey, 2008), 
although newer vacuum cleaners may be more efficient in removing allergens. In the present 
study, 10.0% of the families had central vacuum cleaners, but no association was seen 
between type of vacuum cleaner and allergens levels or reported pet avoidance (results not 
shown). Air cleaners have been recommended for reducing indoor allergens, and may be 
efficient in removing cat allergen, but not HDM allergen which is most often found in settled 
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dust reservoirs such as mattresses, pillows and sofas (Diette et al., 2008; Tovey, 2008). 
Among the 1019 families in the present cohort, only 34 families reported to have air cleaners 
at home, and five families reported air cleaners in the child’s bedroom. Thus, the numbers 
were too low to relate to allergen concentration. Another approach for reducing allergen 
exposure is to remove items that accumulate dust, such as carpets. The concentration of pet 
allergens may be as much as 100 times higher in carpets than on polished floors (Woodcock 
and Custovic, 1998). Floor carpeting is uncommon in Norway today compared to a few years 
ago. In the present study, 15.1% of the families had wall-to-wall carpeting in the living room 
during the child’s first year of life compared to 2.4% at the 10-year follow-up. Similarly, 
33.2% of the children had wall-to-wall carpeting on their bedroom floor during their first year 
of life and 10.5% at 10 years of age.  
Among the families who reported pet avoidance at the 10-year follow-up, 22% had 
nevertheless currently at least one furry pet at home. Ten of these families had always kept 
pets and 58 families had acquired pets after the child’s birth, of which 50% had acquired 
either a cat or a dog. The reported pet avoidance for these families is therefore likely to have 
been directed towards specific types of pets only, as also observed in the ECRHS study, 
where cats but not dogs were avoided (Svanes et al., 2006). 
Recall bias is always a hazard when doing analyses related to events occurring in the 
past. This was assessed at the 10-year follow-up, when the parents were asked questions 
regarding pet keeping during the child’s first year of life and reports were compared to the 0-1 
year questionnaires. At 10 years of age, 24% of the parents failed to report pets and 5% over-
reported pets kept during the first year of life. Moreover, 33% of the parents who 
underreported pet ownership also reported pet avoidance in the same interview. In the 
PIAMA study, the parents were found to overstate the extent to which they avoided pets at 
home because of allergy in one of the family members (Kerkhof et al., 2009). With both 
interviews and questionnaires, the subject’s response to a question may be influenced by 
perceived expectations from the interviewer. However, incorrectly reported pet ownership in 
the present study was not associated with allergic disease in the family, in line with two other 
reports (Nicholas et al., 2009; Svanes et al., 2008). 
The majority of those who underreported pet keeping in the present study had kept cats 
during the child’s first year of life. A recent report on the accuracy of young adults to recall 
having childhood pets, found that both cats and dogs were more likely to be underreported 
than over-reported, and that recall of having cats and dogs was on average “moderate” (kappa 
statistics = 0.41-0.60) (Nicholas et al., 2009). Svanes et al (2008) reported substantial 
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agreement between adults asked about their childhood pets on two separate occasions 9 years 
apart. Interestingly, in the PIAMA study, substantial disagreement between previous parental 
reports on doctor diagnosed asthma was found, when at the age of 8 years, as many as 40% of 
the children with a doctor’s diagnosis of asthma according to prospective data were reported 
not to have had this diagnosis retrospectively (Kerkhof et al., 2009). Thus, recall error of both 
disease and pet keeping can have consequences for the conclusions in studies assessing 
associations of pet keeping and allergic disease development.     
7.2 Associations between pet exposure and allergic disease 
In the present study we found that increased levels of cat allergens at 2 years of age increased 
the risk of current asthma at 10 years of age, but no association was seen with a history of 
asthma. Thus a group of children with a history of asthma did not exhibit symptoms or used 
asthma medication at 10 years of age, representing a phenotype that either suggest they have 
“outgrown” their asthma, that their phenotype is unrelated to pets or that they may be in a 
period of asthma remission. The ‘window of opportunity’ during which environmental 
influences affect the development of later childhood asthma has been suggested to be 
restricted to the prenatal, early postnatal or infant-young pre-school period (Carlsen et al., 
2009; Martinez, 2009), but the length of this period is uncertain. Assuming that cat allergen 
levels measured at 2 years of age are representative for the exposure levels the children 
experienced during the two first years of life, it may explain associations with asthma seen 
later in childhood. However, after stratifying for allergic sensitization, the association 
between increasing cat allergen levels at 2 years of age and the increasing risk of asthma at 
the age of 10 remained significant only for the children without allergic sensitization. 
Separating the risk for asthma and risk for sensitization is challenging, as allergic sensitization 
is a strong risk factor for asthma on it’s own (Anto, 2004). In a long-term follow-up of 
children with early wheezing, early sensitization to cat and dog increased the risk of later 
asthma whereas early exposure to cat or dog had no such effect (Korppi et al., 2008). 
However, reports on time trends in the development of allergic disease in children from the 
former East Germany have reported the prevalence of allergic sensitization also to increase 
for East German children who were born before the unification of East and West Germany, 
whereas the asthma prevalence increase only for children born after the unification (Heinrich
et al., 2002; von Mutius et al., 1998). Thus, factors operating very early in life may be 
particularly important for the acquisition of childhood asthma, whereas the development of 
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allergic sensitization and hay fever may also be affected by environmental factors occurring 
beyond infancy.  
In one population-based birth cohort study, associations between early life exposure to 
cat allergen and asthma at the age of 6 years was found, independent of allergic sensitization 
status (Torrent et al., 2007). Interestingly, this study reports a steep increase in risk at low 
levels of exposure and a flattening above 1 μg/g of dust. It was argued that only for low levels 
of allergens different effects on asthma and sensitization may occur (Torrent et al., 2007). 
This could be an additional explanation also for our findings and a possible explanation for 
the low adjusted odds ratio. Alternatively, allergens may possess an immunological and 
inflammatory mechanisms in addition to IgE responses. Results from studies on the 
proteolytic activity possessed by Der p1 have led to the suggestion that it would be more 
appropriate to consider allergens as polypeptides with a diverse range of biological effects, 
rather than proteins which simply trigger the synthesis of specific IgE (Chapman et al., 2007; 
Wan et al., 1999).  
The children in cohort studies published so far tend to have short follow-up times 
(Apelberg et al., 2001; Simpson and Custovic, 2005), and studies where the exposure is 
assessed shortly before outcome may show a protective effect in healthy children due to 
removal of the exposure in the diseased. Moreover, at very young age, too few children may 
have developed asthma and allergies during the follow-up to be able to detect any associations 
between exposure and disease development. The use of biologically meaningful timing of 
exposure and outcome is therefore of critical importance in studies of risk associations 
(Apelberg et al., 2001; Chen and Heinrich, 2009). 
In relation to exposure-disease associations for allergic diseases, much more attention 
has been given to cats than dogs in epidemiological studies (Simpson and Custovic, 2005). 
One reason may be publication bias due to more documented associations between cat 
allergen exposure and allergic disease development, since, in contrast, most respiratory 
symptoms related to dog exposure appear to be non-allergic (Langley et al., 2005; Nafstad et 
al., 2001; Svanes et al., 1999; Svanes et al., 2003). Thus, the major cat allergen Fel d1 is 
believed to be more allergenic than the major dog allergen Can f1 (Murray et al., 1983). Fel 
d1 has also been found to have enzymatic activity (Wan et al., 1999), although the nature of 
the enzymatic activity is not well known and weak compared to the enzymatic activity of Der 
p1. Moreover, Fel d1 belongs to the group of secretoglobulins, whereas Can f1, belongs to the 
family of lipocalins. The human body contains numerous endogenous lipocalins, and the 
immune system has had to adapt to their presence (Virtanen, 2001). As most T cells reactive 
  52 
General discussion 
___________________________________________________________________________ 
to lipocalins have been eliminated during thymic maturation, a weak cellular response (as 
observed with another lipocalin allergen, Bos d2 (cow)) could be due to the low frequency of 
T cells that are able to bind to Can f1 on allergen presenting cells (Mantyjarvi et al., 2000). 
Another possibility is that the surviving T cells with their low-affinity T cell receptors for self, 
recognize allergen epitopes of lipocalin allergens inefficiently (Mantyjarvi et al., 2000).  
Studies assessing both cats and dogs, have often found that the exposure to cat 
allergens results in more severe symptoms than the effect of dog allergen exposure (Lindfors
et al., 1999; Murray et al., 1983). One possible explanation, as mentioned above, is the nature 
of the Fel d1 allergen. Another explanation may be that cat allergens remain airborne for a 
longer period of time (Luczynska et al., 1990), possibly resulting in higher inhaled doses of 
cat allergens. Airborne dust particles (mostly less than 2.5 μm in diameter) may act as carriers 
of allergens into the airways, and Fel d1, Can f1, and Bet v1 (birch allergen) have all been 
found to bind on the surface of airborne particles, in contrast to Der p1 (Ormstad et al., 1995; 
Ormstad et al., 1998). In addition, airborne particles may also act as an adjuvant causing 
inflammatory responses as well as increasing the production of sIgE (Samuelsen et al., 2008).  
In the present study, we did not find any association between cat and dog allergen 
levels at 2 years of age and specific sensitization to pet allergens later in life. An interesting 
finding was that the majority of children with sensitization to cat and dog at 10 years of age 
had never kept these pets at home (91% and 85%, respectively). These findings are in line 
with other studies where 70% or more of the cat allergic children had never lived in a house 
with a cat (Perzanowski et al., 2002). This implies that low-level exposure to pet allergens is 
sufficient for susceptible individuals to become sensitized, or that they are exposed to much 
higher levels of pet allergens at other places than home (Almqvist et al., 1999; Instanes et al., 
2005; Perzanowski et al., 1999). In the Lifestyle-Immune-System-Allergy (LISA) birth cohort 
study, it was found that early life exposure to cat allergen increased the risk of allergic 
sensitization at 2 years of age, but found no association with allergic sensitization at the age of 
6 (Chen et al., 2007). On the other hand, regular cat contact without ownership increased the 
risk of sensitization to cat during childhood (at both age 2 and 6), but only for those children 
with parental allergic disease (Chen et al., 2007). 
It is likely that susceptible atopic individuals may become sensitized to allergens at 
lower concentrations than individuals that are less susceptible. This may explain the high 
prevalence of sensitization to cat and dog allergens among the children in the present study 
(figure 4) with additional sensitization to both seasonal and perennial allergens. 
Monosensitization is rather uncommon in susceptible atopic individuals, and is more likely to 
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occur in individuals exposed to extremely high levels of allergen and adjuvants, such as in 
occupational settings.  
Cross-reactivity may contribute to the apparent multiple sensitizations. In general, 
patients sensitized to pets (particularly cats and dogs) frequently display IgE reactivity against 
allergenic proteins derived from different animals (Liccardi et al., 2001). This suggests the 
possibility of cross-reactions between common allergenic determinants. In particular, the 
presence of a Fel d1-like allergen has been detected in dog dander extracts (Reininger et al., 
2007). It is therefore possible that some of the individuals with an elevated IgE apparently 
specific to Can f1 (dog), have actually been sensitized to cats rather than dogs.  
Cat and dog allergen levels in mattress dust at 10 years of age were not associated with 
current symptoms of rhinitis, as these children were more likely to avoid pets and to have 
lower allergen levels in their mattress dust compared to children without allergic rhinitis. 
However, the children who were unable to relate any triggers to their symptoms had higher 
levels of dog allergens in their mattress dust compared to the children who reported at least 
one perceived rhinitis trigger. Although this association is of uncertain importance as it was 
not confirmed in the multivariate analyses, few of these children kept dogs and may be 
unaware of the exposure at home, possibly due to transfer of allergens on clothes from contact 
with the allergens elsewhere.  
7.3 The influence of exposure to house dust mite and microbial 
components on allergic disease 
In the present study, the overall exposure to HDM allergen was low. Also in mattress dust 
where the HDM allergen is most common (Custovic et al., 1999), detectable levels were 
demonstrated in only 12.3% of the samples. This is consistent with earlier findings in the 
ECA study with Der p1 allergens measured in mattress dust of the 2-year-old children 
included in the nested case-control group (Nafstad et al., 1998), and with other previous 
reports from Norway (Dotterud et al., 1995; Dotterud et al., 1997). The HDM allergen is 
contained in relatively large mite feces particles, typically 10-40 μm in diameter, and is 
detected in the air of indoor environments only after a strong disturbance (Custovic et al., 
1999; Liccardi et al., 2001). Under undisturbed conditions, HDM allergen may be found only 
in dust reservoirs, such as mattresses, pillows and carpets. Because of the large size, the mite 
feces particles are generally considered non-respirable. Some large particles may enter the 
lung, but the majority are usually cleared very rapidly (Svartengren et al., 1987). However, in 
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regard to sensitization to allergens, this is likely to occur in the mucosa linings of the nose and 
nasopharynx.  
In one previous study from Norway, the few homes with high mite allergen levels 
were homes with poor ventilation, increased humidity and water leakages (Dotterud et al., 
1995). No such associations were found in the present study (results not shown), and in 
general few homes reported problems with water leakages (4.4%) or dampness (5.9%) at the 
10-year follow-up. 
Nevertheless, children with Der p1 sensitization still had higher levels of Der p1 
allergen in their mattress dust compared to children without Der p1 sensitization. Similar 
results have also been found in other studies from Norway (Dotterud et al., 1995; Dotterud et 
al., 1997) and from Sweden (Warner et al., 1996). Our findings are in conformity with the 
notion that the Der p1 allergen is more potent than cat and dog allergens in relation to 
sensitization and allergic inflammation development, possibly due to the intrinsic enzymatic 
activity of Der p1 (Liccardi et al., 2001). Der p1 have several potent effects on the epithelium, 
such as cleavage of proteins of tight junctions resulting in paracellular delivery of allergens 
(Wan et al., 1999). Further, Der p1 may act as Th2 cell adjuvant by cleaving CD23 from 
activated B cells and CD25 from T cells (Chapman et al., 2007). Another explanation for 
allergic sensitization in individuals, who are not exposed to HDM allergen at home, may be 
exposure to the allergen during holidays or other visits to areas where HDM is more prevalent 
(Hallas et al., 2004; Wickman et al., 1993).  
In contrast to other birth cohort studies (Celedon et al., 2007; Douwes et al., 2006; 
Gillespie et al., 2006), we found no evidence of modifying effects of endotoxin in house dust, 
except for a weak association with FEV1 % predicted at 10 years of age, which disappeared 
after removing one extreme outlier. In the study of Celedon et al. (2007) early life exposure to 
endotoxin above the lowest quartile was found to be associated with a reduced risk of atopy at 
school-age, but with an increased risk of wheeze between 1 and 7 years of age. However, 
even the lowest quartile in that study was above the levels of endotoxin measured in the 
homes of the 2-year-old children in the present study. Moreover, the protective effect of 
endotoxin exposure has most often been reported in farming households where exposure is 
likely to occur throughout pregnancy, early post-natal life and throughout infancy, and with 
much higher endotoxin levels than in non-farming households (Liu, 2004). Genetic variation 
in toll-like receptors, TLR2 and TLR4, has also been suggested to be an important 
determinant of the susceptibility to asthma and allergies in children of farmers and in relation 
to high endotoxin exposure, respectively (Eder et al., 2004). Furthermore, the birth cohort 
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studies reporting associations with endotoxin and allergic disease outcomes were all with 
high-risk children and with shorter follow-up time than in the present study (Celedon et al., 
2007; Douwes et al., 2006; Gillespie et al., 2006). Notably, the association between endotoxin 
exposure and reported airway and skin symptoms in 15 months old children, as reported by 
Gillespie et al. (2006), was with only 12 months follow-up time between exposure and 
outcome assessment. Thus, the effect of endotoxin exposure on allergic disease development 
appears to be influenced by the timing of exposure, pre-existing disease and gene-
environment interactions (Williams et al., 2005).  
The paradox that high levels of endotoxin induce asthma-like symptoms is mostly 
observed in an occupational setting (Liu, 2004), and may with continuous exposure lead to 
chronic airway diseases (Schwartz et al., 1995). The present study was not designed to assess 
the effect of continous exposure, and the tendency towards decreased FEV1% predicted at 10 
years of age with increasing endotoxin levels at 2 years of age can not be attributed to 
continued exposure. 
 ß(1,3)-glucans may, like endotoxin, possess inflammatory and adjuvant effects (Novak 
and Vetvicka, 2008; Ormstad et al., 2000). In the present study, we found no association 
between levels of ß(1,3)-glucans at 2 years of age and allergic disease outcomes at 10 years of 
age, which is in line with another prospective birth cohort study assessing asthma, wheeze and 
allergic sensitization in 4-year-old children (Douwes et al., 2006). Concurrent exposure to 
ß(1,3)-glucans have been found to protect against wheezing in farm children (Iossifova et al., 
2007; Schram-Bijkerk et al., 2005), where the levels of ß(1,3)-glucans were found to be 
increased (Schram et al., 2005). Thus, although ß(1,3)-glucans may have immunomodulatory 
effects, the evidence of a causal role for ß(1,3)-glucan in relation to asthma and sensitization 
in humans is still very limited.  
The presence of pets may be associated with both ß(1,3)-glucan and endotoxin levels in 
house dust (Gehring et al., 2001; Gehring et al., 2004), but in the present study we found no 
association between pet keeping and the levels of endotoxin or ß(1,3)-glucans.  
7.4 Gender in relation to pet exposure
In the present study, the 10-year-old boys were more likely than the girls to have current 
asthma, rhinitis, and wheeze and to be allergically sensitized. Sensitization to cat allergen was 
also more common for boys (16.2%) than for girls (8.6%), p=0.001, which may explain why 
boys had less cats at home and were in less contact with cats outside home compared to the 
girls, although not significantly so when assessing cat ownership separately. Boys were also 
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more often sensitized to dog allergen compared to girls (18.3% and 8.1%, respectively, 
p<0.001), but no difference between the genders was seen in regard to dog ownership or 
contact. In general, sensitized children appeared to be more likely to avoid cats than dogs, 
which may be due to the symptoms caused by cat allergen appear to be more severe compared 
to symptoms induced by dog allergen (Murray et al., 1983). The children may also have a 
false confirmed allergy test to dog allergen, as previously discussed, and may therefore be less 
likely to have clinical symptoms when near dogs. On the other hand, the families with other 
furry pets than cats and dogs had also more often daughters than sons, and cat ownership at
birth was also more common in families where the index child was a girl (results not shown). 
Although this is likely to be a statistical coincidental finding at birth, girls favouring furry pets 
might contribute to the association between female gender and pet keeping at 10 years of age. 
Single parenthood was also a significant predictor for cat acquisition after the child’s birth, 
and of these 254 single parents, 78% were single mothers, indicating that also female adults 
are more inclined to keep cats. 
The association between female gender and pets was further supported by pet 
allergens in mattress dust being significantly higher for girls than for boys, regardless of pet 
ownership. In a recent Swedish study more cat keeping was found among girls than boys, 
with a significant interactive effect on the risk for current wheeze (Bjerg et al., 2009). One 
longitudinal study on adults, found female smokers with household pets to be more likely to 
develop asthma during the two-year study period, compared to their male counterparts (Chen
et al., 2002). Moreover, in a previous report from the nested case-control group from the 
ECA-study, gender differences were seen for antenatal maternal smoking and sCD14 levels 
(Lodrup Carlsen et al., 2006b). This supports the hypothesis that environmental factors 
influence the immune system differently in girls and boys, as also proposed by Ronchetti et
al. (1992) who reported parental smoking to enhance allergic sensitization in boys, but not in 
girls (Ronchetti et al., 1992). 
In spite of the difference in allergic diseases in boys and girls and the common 
knowledge that this is not due to biological differences alone, surprisingly few studies have 
assessed differences in exposure between genders. In most studies gender effects are 
recognized and adjusted for in analyses assessing associations between risk factors and 
allergic disease development, thus masking gender as a possible important explanatory factor.  
To our knowledge, the present study (Paper IV) is the first to report differences in indoor 
allergen levels between boys and girls. However, due to the effect of reported pet avoidance 
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on pet keeping for the children with allergic rhinitis, no gender related differences were 
observed between pet allergen levels and current rhinitis in the multivariate models.  
Interestingly, HDM allergen significantly increased the risk of current rhinitis in girls, 
but not in boys. For boys, the association with HDM allergen levels and current rhinitis 
symptoms may be masked due to the strong association between current asthma and current 
rhinitis. Our findings imply that even low levels of HDM allergen in mattress dust may be 
associated with induction of rhinitis symptoms, as well as with allergic sensitization, as 
previously discussed.  
7.5 Strengths and limitations 
The ECA study is a prospective birth cohort study which was designed to investigate asthma 
and factors associated with asthma development during childhood, with emphasis on 
environmental exposures. It contains a well characterized population of mainly, but not 
exclusively, Norwegian ethnicity. The half-yearly prospective questionnaires during the two 
first years of life reduce the risk of recall bias and misclassification thereby increasing the 
level of evidence. The 84% participation rate at 10 years of age is high and few other 
European birth cohorts have, so far, had such a long follow-up time (Keil et al., 2006). The 
high participation rate also reduces the risk for inclusion bias. 
At 10 years of age the definition of asthma ever was based on a combination of 
symptoms, medication and clinical diagnosis. Current asthma included the objective measure 
of airway bronchial hyperresponsiveness by treadmill running. These definitions reduce the 
risk of misclassification thereby increasing the validity of our findings. Further, we included 
the core questions from the standardized ISAAC questionnaires, making it possible to 
compare our results with other studies.         
The clinical examination of all children was performed by study doctors with 
experience in paediatric pulmonology and allergology, and all staff involved in the 10-year 
follow-up study were blinded to the results of the lung function measurements at birth as well 
as to all other previous results. 
The 10-year follow-up study is asthma-enriched due to the inclusion of the nested 
case-control group (at 2 years of age), where the cases had rBO. As previously discussed, this 
was either corrected for by weighted prevalence analyses (Paper III) or with rBO included as 
a potential explanatory variable on its own (Paper I). The concurrent allergen levels and 
rhinitis symptoms assessed in Paper IV, were probably unrelated to rBO status during the two 
first years of life. rBO was already confirmed not to be associated with pet avoidance (and 
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thus correspondingly lower pet allergen levels), and the intention of the study was 
nevertheless to study the association between concurrent exposure and rhinitis symptoms and 
not early life risk factors of rhinitis. 
Cohen’s kappa () (Landis and Koch, 1977) was used to assess the agreement between 
SPT and sIgE antibody > 0.35kU/L specific for cat and dog allergens for the children included 
in the 10-year follow-up study. The agreement between SPT and sIgE was  = 0.82 for cat 
and  = 0.60 for dog allergen. According to Landis & Koch (1977) 0.60 - 0.80 represent a 
substantial agreement and 0.80 - 1.00 an almost perfect agreement. The lower agreement 
between SPT and sIgE antibodies for dog allergen may be due to the Fel d1-like allergen in 
the dog dander extract used for detection of sIgE to dog (Reininger et al., 2007). Our results 
might have been different if allergic sensitization to a specific allergen had been defined by 
both a positive sIgE and SPT, or by either of these alone.  However, our outcomes were most 
often related to sensitization to any inhalant allergen and the majority of the children were 
nevertheless sensitized to more than one allergen. 
7.6 Future perspectives
The results of the papers included in the present thesis raise some important questions. First, 
how do pet keeping during the first years of life and throughout childhood affect the 
development of allergic disease later in adolescence? By following children included in the 
birth cohort into adolescence, we may use prospectively collected information on allergen 
levels, pet removal and pet acquisition and see how this relates to development of allergic 
disease later in life. Further, considering our finding that few families removed their pets, it 
would be of interest to assess how allergic diseases at 10 years of age affected pet removal 
later in childhood or adolescent.  
Studies assessing microbial substances and allergens in house dust have often given 
conflicting results in relation to exposure-effect associations, and also the amount of dust 
alone appears to affect the development of allergic diseases (Gehring et al., 2007). Thus, 
factors that we so far do not fully comprehend may interact with these exposure-effect 
associations, or the microbial substances measured in house dust may be surrogate markers 
for something else. The second question is therefore whether there are other agents in the dust 
samples than may affect the development of allergic disease? One possibility is pollen and 
food allergens. Although both allergens have been measured in indoor dust reservoirs 
(Dotterud et al., 1997; Fahlbusch et al., 2001), few studies have assessed the association with 
food and pollen allergen levels in house dust and the development or exacerbation of allergic 
  59 
General discussion 
___________________________________________________________________________ 
diseases. In addition to biological factors, chemical factors such as phthalates may also affect 
the immune system, and can be quantified in dust samples and also be measured as 
biomarkers in urine. It has been of growing concern that everyday exposure to these and other 
chemicals through food, water and air may have impact on immune diseases, like asthma and 
allergy. However, the level of exposure in Norwegian children is not well known, and there 
are so far only a few epidemiological studies that have investigated the association between 
the so called ‘modern’ chemicals and allergic diseases. 
Thirdly, it would be of interest to study how factors in the indoor environment contribute 
to allergen levels in the indoor environment, such as ventilation (mechanical vs natural), 
dampness, and different types of dwellings. Finally, further studies on differences in exposure 
and effects between boys and girls appear warranted and might also shed some light on the 
mechanisms involved.
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8 CONCLUSIONS
Based upon the results from the present work concerning children included in the ECA study 
in Oslo and previous knowledge in the research areas as discussed in the present thesis, the 
following conclusion can be drawn on the specific research questions: 
 
 1. The results from the present work show that allergic disease in the family did not 
significantly decrease the likelihood of pet keeping at the child’s birth. However, when the 
index child had allergic rhinitis, the families often avoided keeping cats and dogs. Reported 
pet avoidance appeared to be most common in families where the parents had high education, 
whereas pet removal even after appearance of symptoms of allergic disease, was uncommon 
in the present cohort. 
 
2. In a sub-group of children from the ECA-study, early life exposure to cat allergen was 
found to increase the risk of asthma at 10 years of age, but no association was seen between 
the levels of pet allergens in the home at 2 years of age and allergic sensitization at 10 years 
of age. Cat and dog allergen levels in mattress dust at 10 years of age were not associated with 
current symptoms of rhinitis.   
 
3. House dust mite allergen levels measured in homes in Oslo were generally low, but 
children who were sensitized to house dust mite allergen, Der p1, had significantly higher 
levels of allergens in their mattress dust than those who were not sensitized to Der p1. 
Endotoxin and ß(1,3)-glucan levels in house dust at 2 years of age did not modify the allergen 
or pet-related risk of allergic disease or lung function at 10 years of age. 
 
4. Girls were more likely to keep furry pets and were also exposed to higher levels of cat and 
dog allergens at 10 years of age. However, in the multivariate analyses, house dust mite, but 
not cat and dog allergen levels, were associated with an increased risk of current rhinitis, but 
this was observed among girls only. 
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Table S1 Information from questionnaires at birth to age 2 and from interview at age 10 
(translated from Norwegian) 
Index
child’s age 
Questions Outcomes/definitions
6, 12, 18 and 
24 months
Has the child had atopic eczema during the last 6 
months?
Atopic eczema by age 2
Has the child ever had any of the following 
symptoms irrespective of a cold: runny nose,
blocked nose, sneezing and/or itching/runny eyes?
Has the child ever had any allergies confirmed by a 
doctor? (not including food-allergies)
Allergic rhinoconjunctivitis
ever
Has the child ever had a diagnosis of asthma
confirmed by a doctor? 
Ever diagnosed with asthma
10 years
Has the child previously experienced respiratory
(wheezing) symptoms caused by furry pets?
Wheezing symptoms due to 
furry pets 
Have any of the following family members ever had 
asthma: Father, mother or siblings?
Siblings or parents with a 
history of asthma
Have any of the following family members ever had 
rhinoconjunctivitis: Father, mother or siblings?
Siblings or parents with a 
history of rhinoconjunctivitis
Birth
What was the total family gross income last year?
1:<100, 2:100-199, 3:200-299, 4:300-500,5:>500  in
1000 NOK 
Family income 
Birth Do mother and/or father smoke at home (sometimes
or daily)?
Parental smoking at birth 
10 years Did mother and/or father smoke at home a) before 
school-age (age 6-7) b) after school-age 
Parental smoking (after child’s
birth)
Birth and 10
years
Which type of house does the child live in?
a) flat b) detached/semi-detached house. 
Type of house at birth 
Moved from flat to house 
(same type of housing vs 
moved from flat to house)
Birth
Father and mother highest completed education: a) 
compulsory (± 1-2 year county college) b) college c) 
university
Parents’ education (highest 
education by either parent) 
With whom does the child live with more than 
>50% of the time? a) mother and father b) mother c) 
father
Single parenthood
10 years
Have the family avoided pets or removed pets due 
to allergy in the family and/or to prevent the child 
from developing allergies? 
Reported pet avoidance
Birth,
6,12,18,24
months and 
10 years
Do you keep furry pets at home? If yes: a) cat b) 
dog c) other types of furry pets (rodents) 
Cats, dogs or other furry pets 
at birth 
Change in pet ownership
from birth to age 10
10 years Did you keep cats, dogs or other furry pets at home 
during the child’s first year of life?
Recall information regarding 
pet keeping first year of life
Table S2 Predictor variables associated with reported pet avoidance
Predictor variables 
% with 
reported  pet 
avoidance
Adjusted OR (95% CI)a
Index child with atopic eczema ever during 
the 2 first years of life
No 24.4 1
Yes 43.2 1.88(1.39-2.54) 
Index child with allergic rhinoconjunctivitis 
ever
No 27.8 1
Yes 61.8 3.05(1.99-4.67) 
Index child ever diagnosed with asthma
No 26.9 1
Yes 48.2 1.83(1.31-2.58) 
Parental rhinoconjunctivitisb
No 25.2 1
Yes 48.7 2.36(1.72-3.23) 
Parental asthmab
No 28.5 1
Yes 57.0 2.41(1.59-3.65) 
Parents’ education
Compulsory 18.6 1
College 31.5 2.29(0.96-5.48) 
University 34.5 2.86(1.21-6.78) 
a Adjusted odds ratios (OR) and 95% confidence intervals (CI) estimated by bivariate and multivariate logistic regression 
models (backward (manual) elimination technique). The other variables initially included, but not significant in the final 
model, were index child’s recurrent bronchial obstruction (rBO) by age 2 years, siblings asthma or rhinoconjunctivitis and 
parental smoking ever. 
breported at index child’s birth 
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Methods
Dust sampling and extractions
The dust samples were collected by the parents according to detailed written instructions. 
They were asked to use new vacuum cleaner bags, vacuum the floor of the living area of the 
house and collect the entire sample of dust from the bags. The dust samples were sent in 
plastic bags to the Norwegian Institute of Public Health and stored at -20°C until extraction 
and analysis. Endotoxin, allergens and ß(1,3)-glucans were extracted sequentially. First, 5 to 
40 ml 0.05% (v/v) Tween-20 in pyrogen-free water was added, determined by the net dust 
weight (<0.5 g, 5 ml; 0.5-1.0 g, 10 ml; 1.0 to 2.0 g, 20 ml; >2.0g, 40 ml). The suspensions 
were incubated in an end-over-end roller for 1 h at room temperature, and after centrifugation 
(15 min, 1000 x g) the upper 10% of the supernatant was harvested and stored in four aliquots 
at -20°C for endotoxin analysis. For the second step, the removed supernatant was replaced 
with the same volume of 10 x concentrated phosphate-buffered saline (PBS), thus changing 
the extraction medium into PBS-0.045% Tween-20 (PBT). After re-suspension and thorough 
mixing of the first pellet in the new medium, incubation was continued in the end-over-end 
roller (1 h), followed by centrifugation (15 min, 2000 x g). The supernatant was harvested and 
stored at -20°C for analysis of cat, dog and mite allergens. The remaining dust pellets were re-
suspended in the original volume of PBT (0.05%), incubated in an end-over-end roller again 
for 15 min, autoclaved for 1 h at 120°C and incubated in an end-over-end roller again for 15 
min. After centrifugation (15 min, 1000 x g), the supernatant was harvested and stored at -
20°C until analysis for ß(1,3)-glucans. 
Analyses of cat, dog and mite allergens, endotoxin and ß(1,3)-glucans 
The concentrations of cat allergen (Felis domesticus Fel d1) and mite allergen 
(Dermatophagoides pteronyssinus Der p1) were determined by enzyme-linked 
immunosorbent assay following mainly the manufacturer’s instructions (Indoor 
Biotechnologies, Clewyd, UK) [1]. Monoclonal antibodies were used as capture and detection 
antibodies. The enzyme-labelled secondary detection reagent used in the assays was alkaline 
phosphatase-conjugated avidin (DAKO A/S, Glostrup, Denmark). A series of dilutions of 
reference cat dander preparation or Der p1 extract (both Indoor Biotechnologies) were 
included on every plate to provide a standard curve. The concentrations of dog allergen 
(Canis familiaris Can f1) was measured with a monoclonal capture antibody (Indoor 
Biotechnologies), polyclonal rabbit anti-Can f1 as detection antibody (ALK laboratories, 
Hørsholm, Denmark) and alkaline phosphatase-labeled donkey anti-rabbit IgG (Jackson 
ImmunoResearch Laboratories, West Grove, USA) as secondary enzyme-labelled antibody. A 
series of dilutions of reference dog hair and dander extract (NIBSC, Hertfordshire, UK) was 
included on every plate to provide a standard curve.
ß(1,3)-glucans were measured with an inhibition Enzyme Immuno Assay (EIA) [2]. Flat-
bottom microtiter plates were incubated overnight at 4°C with Laminarin (BioChemika 
(Sigma-Aldrich, St.Louis, USA)) (16 µg/ml) in PBS (200 µl per well). After washing, 300 µl 
of 0.2% gelatine in PBT (PBTG) was applied, the mixture was incubated at 37°C for 1 h, and 
the gelatine solution was discarded. A test sample or a laminarin standard (100 µl diluted in 
PBTG) was then added to a microwell and subsequently mixed with an equal volume of 
affinity-purified anti- ß(1,3)-glucan antibodies (Batch 9819, provided by Dr. G. Doekes, 
IRAS, Utrecht, The Netherlands) diluted 1/40 000 in PBTG. The microtiter plate was then 
shaken at 37°C for 1.5 h. After washing, 200 µl of peroxidase-labelled swine anti-rabbit 
immunoglobulin antibodies (DAKO A/S) diluted 1/2000 in PBTG was added and the mixture 
was shaken for 1 h at 37°C. After washing, 200 µl of SIGMA FASTTM OPD (o-
phenylenediamine dihydrochloride) was added and the mixture was incubated for 30 min at 
20°C. The enzyme reaction was terminated by addition of 50 µl of 2 M HCl, and the optical 
density was read at 490 nm. Concentration was expressed as µg ß(1,3)-glucan per gram dust.
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 ABSTRACT 
Rhinitis and its co-morbidities affect quality of life, and in children little is known. We 
therefore aimed to describe the co-morbidities and phenotypes of current rhinitis in 10-year-
old Norwegian children. Information on rhinitis, asthma, allergic sensitization and lung 
function tests was retrieved from clinical examinations and structured parental interviews of 
1019 children included in the birth cohort study, ECA, in Oslo. Current rhinitis was reported 
in 254 (25.0%) of the children, and 87% had at least one allergy-related co-morbidity of 
rhinitis, with conjunctivitis the most prevalent (75.6%). Overall, 11.8% of the children had 
conjunctivitis combined with current asthma and atopic eczema. Children with rhinitis were 
also more likely to have severe bronchial hyperresponsiveness (BHR) (PD201 μmol 
methacholine) than children without rhinitis (17.5% and 5.8%, respectively, p<0.001), as well 
as BHR (PD20 8 μmol). The children with rhinitis and allergic sensitization (72.8%) had 
more frequently BHR, severe BHR and conjunctivitis, but did not differ with respect to any 
other co-morbidity from children with rhinitis without allergic sensitization. Children with 
symptoms reported both by exposure to pollen and furry pets had more often asthma, wheeze 
and BHR compared to the children who reported rhinitis symptoms only when exposed to 
pollen (91.9% of these had symptoms in spring/summer only). In conclusion, current rhinitis 
is closely associated with conjunctivitis, asthma, atopic eczema, and BHR in childhood. 
Conjunctivitis and BHR were most strongly linked to rhinitis with allergic sensitization. 
 
Keywords: BHR, children, co-morbidity, medication, phenotypes, rhinitis, triggers of rhinitis 
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 INTRODUCTION
Chronic rhinitis is a common disease, which together with frequent co-morbidities such as 
asthma, bronchial hyperresponsiveness (BHR) (1, 2), conjunctivitis (3) and otitis media (1, 4) 
may affect quality of life (1, 2, 5). The co-morbidities have been described by the type of 
allergens associated with the rhinitis symptoms, and rhinitis related to exposure from 
perennial allergens has been more closely associated with asthma (2) and BHR (6) than with 
rhinitis related to pollen exposure. It is, however, unclear whether patients who are sensitized 
to more than one allergen (polysensitization) have more co-morbidities and more severe 
phenotypes than those who are monosensitized (7). Although co-morbidities of allergic 
rhinitis are well described in adult populations, less is known in childhood (1, 7). 
IgE-mediated hypersensitivity of the nose often referred to as allergic rhinitis (8), is 
currently classified into intermittent and persistent, as well as mild or moderate-severe (9). 
Although allergens are common elicitors of rhinitis symptoms, rhinitis may also be 
precipitated by infections, occupational exposure, drugs, hormones, foods, tobacco smoke, 
emotion and physical or chemical triggers (9). For practical purposes and lack of adequate 
phenotype categories in childhood, the majority of children with rhinitis symptoms outside 
respiratory infections have been classified by the presence or absence of IgE or skin-test 
reactivity to allergens, into allergic or non-allergic rhinitis (3). However, the role of allergens 
in elicitation of rhinitis in the absence of evidence of systemic IgE sensitization may be 
underappreciated, as local IgE production may underlie the disease expression (10), and little 
is known on the phenotypes and co-morbidities of rhinitis in children without detectable 
systemic IgE sensitization (7, 11). 
We therefore aimed to investigate the co-morbidities of current rhinitis in 10-year-old 
children and secondly to describe the clinical phenotypes identified and the treatment reported 
for rhinitis in this age group.  
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 MATERIAL AND METHODS 
Study design and subjects 
The present study is part of the birth cohort study The Environment and Childhood Asthma 
Study (ECA) initiated in Oslo in 1992 and described in detail elsewhere (12). The study 
enrolled 3754 healthy full-term babies whose parents were sufficiently skilled in Norwegian 
language to complete the 6-monthly questionnaire from birth to 2 years of age.  
Within the birth cohort 802 children, not differing from the entire general birth cohort 
population with respect to most relevant factors (12), had lung function measured at birth 
(13). At 2 years of age a nested case-control study recruited 612 children from the entire ECA 
study, including children with recurrent or persistent bronchial obstruction (rBO) by 2 years 
and controls with no bronchial obstruction born closest in time to the cases (14). The children 
were clinically examined 1-2 times between birth and the age of 2, with at least one 
investigation in 562 children (figure 1). 
All the 1215 children with lung function measured at birth and/or a clinical 
investigation by 2 years were invited to participate in a 10-year follow-up. In total 1019/1215 
(84%) (figure 1) of the children participated in the 10-year follow-up study with two clinical 
examinations performed 2-7 days apart and at least 4 weeks after any suspicion of respiratory 
tract infection. The examinations included blood tests, skin prick tests for allergic 
sensitization, lung function by forced flow-volume measurements, bronchial 
hyperresponsiveness measures by methacholine challenge test and a treadmill exercise test, as 
well as a parental structured interview.  
Comparison of the demographic birth characteristics of the children included in the 
follow-up and those who were not included have previously been described (15). The 
included (n=1019) and non-included children (n=2735) were in general comparable, except 
that the included children had more often parents and sibling with rhinoconjunctivitis and 
asthma than the non-included children (31.7% and 26.9%, respectively, p=0.004 for 
rhinoconjunctivitis) and 17.7% vs 14.8%, respectively (p=0.03) for asthma. 
Written informed consent was obtained from the parents, and the study was approved 
by the Regional Committee for Ethics in Medical Research and the Norwegian Data 
Inspectorate and reported to the Norwegian Biobank Registry. 
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 Methods
The 10-year follow-up 
A parental structured interview included central ISAAC questions related to airway 
symptoms of the child, in addition to detailed questions regarding environmental exposure, 
life-style, diseases (index child and family) and medication. The questions related to rhinitis 
focused upon symptoms, medication, triggers, and possible impact the symptoms had on daily 
life activities (table 1). 
 Skin prick tests (SPT) were performed according to the European standard (16) with 
the following standardized allergen extracts from ALK (Soluprick®, ALK-Abello, Denmark): 
House dust mites (HDM) (Dermatophagoides pteronyssinus and Dermatophagoides farinae), 
German cockroach, dog, cat and rabbit, birch, timothy (grass) and mugwort pollens, moulds 
(Cladosporium herbarium and Alternaria), egg white, milk, peanut and codfish. SPT were 
considered positive with a mean wheal diameter at least 3 mm larger than the negative control 
(saline).  
Total and specific serum IgE (IgE and sIgE, respectively) were analysed with a 
radioallergosorbent fluorescence immunoassay (ImmunoCAP® system, Phadia, Uppsala, 
Sweden) according to the instructions by the manufacturer. Specific IgE was analysed with 
the same panel of allergens as for SPT and considered positive with sIgE 0.35 kU/L. The 
lower detection limit was 0.1 kUA/L for sIgE and 0.1 PAU/L for total IgE. 
Baseline spirometry was measured according to European standards (17) on a Sensor 
Medics Vmax 20c (SensorMedics Diagnostics, Yorba Linda, CA, USA) prior to and after 
methacholine and exercise challenge tests on separate days. Lung function was reported as per 
cent predicted of forced expiratory flow at 50% of vital capacity (FEF50) and forced 
expiratory volume in one second (FEV1) [reference values of healthy 10-year old children 
from the ECA-study obtained by methods described by Stanojevic et al. (18)].  
 
BHR was tested directly and indirectly, respectively by:  
a) Methacholine challenge test assessed according to international guidelines (19), by 
doubling the cumulative dose of methacholine and reported as the dose of 
methacholine causing a fall in FEV1 of 20% from the (post-saline) baseline value 
(PD20 methacholine)  
b) A standardized exercise test (20) performed on the second day by a 6-8 minutes 
treadmill run at 95% estimated maximum pulse level, and an incline of 5% of the 
treadmill. The response was measured as maximum fall in FEV1 assessed before and  
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 3, 6, 10, and 15 minutes after running. The exercise test was considered positive for 
exercise-induced bronchoconstriction (EIB) with a fall in FEV1>10% of baseline FEV1  
 
Definitions
Allergy-related co-morbidities were defined as current conjunctivitis, asthma, atopic eczema, 
and otitis media. 
Current rhinitis was present in a child reporting at least one of the following 
symptoms during the last 12 months (without a cold): runny nose, blocked nose, or sneezing 
(table 1). Conjuntivitis required a report of itchy/runny eyes during the last 12 months.  
Rhinitis with allergic sensitization was defined in a child with rhinitis combined with 
at least one positive SPT and/or sIgE to any of the inhalant allergens: seasonal (pollens or 
moulds) or perennial (house dust mites, cat, dog, rabbit or cockroach). Mixed sensitization 
was defined with SPT/sIgE positive to at least one seasonal and one perennial allergen. 
BHR was defined as a categorical variable with three groups: PD20 methacholine 
1μmol, >1 to 8 μmol and >8 μmol, and as a continuous variable with the methacholine 
dose-response slope (DRS) calculated from each individual (per cent decline in FEV1 after the 
final dose of methacholine divided by the cumulative dose of methacholine inhaled) (21).  
Current asthma was defined in children by the presence of at least two of the three 
criteria; asthma symptoms, doctor diagnosis of asthma and/or use of asthma medication, and 
either symptoms or use of asthma medication within the last 12 months and/or a positive 
exercise challenge test at the 10 year follow-up visit (12). 
Current wheeze required a positive response to the question “Has your child 
experienced dyspnoea, chest tightness and/or wheezing during the last 12 months?” 
Otitis media was defined by reported otitis media during the last 12 months, and atopic
eczema by a positive response to present or having ever had atopic eczema.  
 
Statistical analyses 
To adjust for the enrichment of children with bronchial obstruction during the first 2 years of 
life, an overall prevalence of rhinitis was calculated by the weighted mean of the prevalence 
of rhinitis for the following groups: (i) rBO by age 2 (ii) controls, and (iii) the follow-up 
children who were not included in the case-control group. The rhinitis prevalence was 
calculated for girls and boys separately (six groups in total), and the weight was the number 
of children in each group. The calculated weighted prevalence is reported with confidence 
intervals. Categorical variables were compared using Pearson’s chi-square test. One-way 
6 
 ANOVA analysis was used to compare DRS and total IgE (both log-transformed) and 
presented as geometric mean with 95% confidence intervals (95% CI). FEV1 and FEF50 % 
predicted was presented as mean with 95% CI. A logistic regression analysis was used to 
assess the association between current rhinitis and increasing number of sensitizing allergens. 
P-values 0.05 were considered significant. Statistical analyses were performed with 
Statistical Package for Social Sciences (SPSS version 14.0, SPSS Inc., Chicago, Illinois, 
USA).  
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 RESULTS
Prevalence of symptoms of current rhinitis
Information on current rhinitis was available for 1015/1019 children from the 10-year follow-
up, and 254 (25.0%) of these children had symptoms of current rhinitis. More than one 
symptom was reported by 72%. The crude prevalence was similar to the calculated prevalence 
adjusting for the enrichment of children with rBO during the first two years of life: 25.0%, 
95% CI: (22.3, 27.7).  
Rhinitis co-morbidities
At least one allergy-related co-morbidity was reported in 87.0%, and 42.9% had at least two 
co-morbidities (figure 2). Combined rhinoconjunctivitis, current asthma and atopic eczema 
were found in 11.8%. The most common co-morbidity to rhinitis was conjunctivitis 
symptoms (itchy or runny eyes) reported in 192/254 (75.6%)) whereas the latter was reported 
as the only symptom in 28 children. Compared to those without rhinitis, children with current 
rhinitis had a higher prevalence of current asthma (31.7%), wheeze (32.1%), current atopic 
eczema (30.3%), and more frequently BHR (PD20  8 mol), severe BHR (PD20  1mol) as 
well as higher DRS (all p<0.001, table 2). Children with combined rhinoconjunctivitis 
symptoms did not differ in other co-morbidities compared to children with rhinitis symptoms 
only. Children with rhinitis had similar rates of allergic sensitization whether they had asthma 
or not (78.5% and 70.0% respectively, p=0.16). The children with rhinitis, but no asthma, had 
more frequently BHR (PD20  8mol) than children with neither asthma nor rhinitis (29.2% 
and 21.7%, respectively) and similar for severe BHR (PD20  1mol) (10.1% and 4.7% and 
respectively), p=0.001. 
 
Allergic sensitization and rhinitis phenotypes 
Timothy grass, birch, dog, cat and mugwort were the most prevalent sensitizing inhalant 
allergens in the present study (figure 3a). Among children with rhinitis, 185 (72.8%) were 
sensitized to at least one inhalant allergen and the majority had mixed sensitization (64.9%), 
whereas 25.9% were sensitized to seasonal allergens only. Rhinitis children with compared to 
children without sensitization to inhalant allergens had significantly more often conjunctivitis 
(85.9 vs 47.8%, respectively, p<0.001), BHR and severe BHR and a positive EIB test (table 
3). They were similar in relation to current asthma, wheeze, otitis media and atopic eczema 
(table 3).  
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 The children who were sensitized to more than one allergen (polysensitization) 
(n=266) were twice as likely to have current rhinitis compared to the children who were 
monosensitized (n=83) (59.8% vs 31.1%, respectively, p<0.001). The 26 rhinitis children who 
were monosensitized were mostly sensitized to pollens; timothy grass (n=11), birch (n=10) 
and mugworth (n=2). More severe BHR (PD201) was common for children with 
polysensitization compared to children who were monosensitized (20.5% and 9.8%, 
respectively, p=0.005), and polysensitized children had also more often current asthma 
(29.0%) than the children with monosensitization (13.4%), p=0.005. Moreover, the likelihood 
of rhinitis increased with increasing number of allergic sensitizations (figure 3b), with odds 
ratio 1.45, 95% CI: (1.25, 1.68), p<0.001. 
Specific triggers of rhinitis symptoms were not indentified in 55 children, and only 
five reported symptoms triggered by temperature alterations or physical activity. The 
remaining 194 children reported rhinitis symptoms triggered by allergens. They were more 
likely to be allergic sensitized (85.1%) and to suffer from conjunctivitis (88.7%) than those 
with unknown or non-allergen triggers (33.3%), (both p<0.001). There was also a tendency 
towards more wheeze in the children with allergen triggered rhinitis (p=0.057), but they were 
otherwise comparable in the other potential co-morbidities of rhinitis (all p>0.2, figure 4).  
Overall, 178/254 (70.1%) reported rhinitis symptoms after exposure to pollen (125 to 
pollen only and 53 to pollen and furry pets), whereas 15 children reported symptoms only 
when exposed to furry pets. Children with both pollen and furry pets as perceived triggers had 
more frequently co-morbidities of BHR, asthma and wheeze compared to the children with 
symptoms only related to pollen (table 4). The majority of the children with pollen-triggered 
rhinitis had a mixed sensitization status (50.4%), whereas 28.8% were sensitized to seasonal 
allergens only and 18.4% were not sensitized to any inhalant allergens (table 4). As expected, 
most of the children with rhinitis related to pollen exposure only reported symptoms in 
spring/summer season (91.9%). In spite of less co-morbidities, they were more likely to have 
symptoms with moderate/severe impact on daily life activities (52.0%) compared to children 
with pollen and furry pets as perceived triggers (35.8%, p=0.048).  
Regardless of rhinitis symptoms, the children with mixed sensitization had more 
frequently severe BHR (PD201) (23.5%) than the children with a seasonal allergen 
sensitization only (7.8%), p=0.001 and similar for DRS (GM: 3.15, (95% CI: 2.3, 4.24) for 
mixed vs 1.45 (1.02, 2.05) for seasonal sensitization, p=0.001). However, the children with 
sensitization to perennial allergens only did not differ in BHR (PD20 methacholine and DRS) 
from the children with a mixed sensitization (both p>0.1). 
  9 
 Medical treatment of rhinitis
Overall, 177/254 (69.7%) of the children with current rhinitis had received medical treatment 
due to rhinitis, most often systemic (n= 149, 58.7%) or topical (38.6%) antihistamines 
whereas 29.9% had used both types of antihistamines. Treatment with alternative or 
complementary medicine was reported in 18 children (7.0%), 14 with homeopathic medicine. 
The alternative medicine was mostly (n=16) used as complementary to traditional medicine.  
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 DISCUSSION
Current rhinitis was reported in 25.0% of 10 year old children, and was associated with at 
least one allergy-related co-morbidity in 87.0%, and 42.9% had at least two co-morbidities. 
Most common were conjunctivitis, current asthma, and atopic eczema, but they were also 
likely to have current wheeze and BHR. Seventy-three per cent of the children with rhinitis 
were sensitized to at least one inhalant allergen and these children had more frequently 
conjunctivitis and BHR, but did not differ in other co-morbidities compared to the children 
without allergic sensitization.  
As many as 11.8% of the children with current rhinitis (3.0% of all children in the 
present study) had all three co-morbidities of conjunctivitis, asthma and atopic eczema 
present, which are much higher than the reports from the ISAAC study (0.6 - 1.1% of 13-14 
year old children from Europe) (22). For the rhinitis children in the present study, 
conjunctivitis was the most commonly reported co-morbidity by 75.5%. Thus 
rhinoconjunctivitis is likely to be one disease entity for the majority of children in this age 
group with allergic sensitization and rhinitis. The 25.0% prevalence of current rhinitis in the 
present study is in line with the findings of the ISAAC study, phase three (22) which reported 
symptoms of rhinitis in 23.4% - 31.2% of the 13-14 year old European children. Current nose 
and eye symptoms was reported for 9.8% - 15.2% (22) compared to 18.9% in the present 
study.  
The link between asthma and allergic rhinitis is well established (9), and confirmed in 
the present study as almost one in three children (31.7%) with rhinitis had asthma. We also 
found that BHR was associated with rhinitis, as has previously been confirmed by others (23), 
but not different between children with rhinitis with and without conjunctivitis, as in line with 
the MAAS study (24). Although BHR is a feature of asthma, it is non-specific, and in the 
present study, BHR was associated with rhinitis also in children without current asthma. 
Moreover, because rhinitis and asthma often co-exist, co-morbidities and symptoms of 
chronic rhinitis may be attributed to a common airways disease starting at the nose and 
including asthma (1, 2). However, allergic sensitization in children with rhinitis was similar in 
children without (70.0%) and with asthma (78.5%) supporting the notion that the co-existence 
of asthma and rhinitis is not solely due to atopic predisposition in these two diseases (2).  
Children in the present study with rhinitis were much more likely to suffer from 
conjunctivitis symptoms if they had allergic sensitization (85.9 vs 47.8%) most commonly 
reported as mixed sensitization. This is in line with another report (80% mixed sensitization) 
although including only subjects that suffered from allergic rhinitis alone (25). Conjunctivitis 
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 was reported to be more common among subjects with seasonal (64.9%), than with perennial 
(46.4%) or mixed sensitization (47.9%) (25). In phase two of the ISAAC study (3) 
associations of rhinoconjunctivitis was more common with sensitization to seasonal allergens 
[population attributable fraction in affluent countries (36%)] than with perennial allergens 
(25%). However, mixed sensitization status was not assessed in the ISAAC study. Also, the 
present children with rhinitis symptoms reported to be triggered both by exposure to pollen 
and furry pets had more asthma, wheeze, and frequently BHR than children with symptoms 
reported to be triggered exclusively by pollen. Also in regard to sensitization status, children 
with a mixed sensitization had more severe BHR than children sensitized to seasonal 
allergens only. Others have also reported that the risk of asthma was higher for young adults 
with rhinitis when exposed to pollens or to animals compared to those with rhinitis related to 
only one of these triggers (2). Moreover, sensitization with concomitant exposure to perennial 
allergens is shown to enhance the development of BHR in children with asthma or wheeze 
(26, 27). Thus, in addition to assessing sensitization status, it is also important to know the 
actual trigger of the symptoms.  
Pollen particles may be quite large, and are thus more easily trapped in the nose, 
inducing a local allergic response, without necessarily inducing symptoms in the lower 
respiratory system (28). This could explain why children with pollen-triggered rhinitis had 
less often co-morbidities of current asthma, wheeze and BHR compared to children with 
symptoms triggered by pollen and furry pets. The latter group also tended to have lower 
FEF50 % predicted and more often a positive EIB test. Severe symptoms on daily life 
activities were mostly reported by children who had pollen-triggered rhinitis, which may be 
explained by these patients being less well adapted to bouts of sneezing and runny nose 
during the pollen season, in comparison to the patients with more chronic nasal obstruction 
due to exposure to perennial allergens. Furthermore, the majority of children without 
detectable allergic sensitization still reported symptoms of rhinitis related to allergens (most 
often pollen). This is in line with reports on patients with non-allergic rhinitis who most 
frequently reported exposure to pollen (and house dust) as the cause of their rhinitis 
symptoms (29).  
In the present study, 7.0% of the children with rhinitis had used alternative medicine, 
and most often homeopathic medicine. In a large study from Germany and Switzerland, 
allergic rhinitis was one of the most common diagnoses among patient using homeopathic 
medicine (30). The frequent use of alternative and complementary medicine in children with 
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 rhinitis and asthma are most often due to dissatisfaction with conventional therapies and 
concerns about steroid side-effects (31).   
 
Limitations of the study
The phrasing of the questions regarding rhinitis in the parental interview does not allow us to 
categorize the children according to the ARIA document (9) which recommends that the old 
terms ‘seasonal’ and ‘perennial’ should be replaced by the terms intermittent allergic rhinitis 
and persistent allergic rhinitis, respectively. Many of the children in Oslo with symptoms 
related to pollen would be in the category of persistent allergic rhinitis, due to the long pollen 
season [approximately 3-4 months (including 6-8 weeks for grass pollen)]. Patients with 
pollen-triggered rhinitis may have a greater bronchial hyperresponsiveness during 
spring/summer seasons (25), but in the present study, we aimed to avoid clinical examinations 
and methacholine challenge testing during the pollen season. We cannot exclude the presence 
of rhinosinusitis (infectious rhinitis) (9) in the children with unknown triggers of rhinitis, but 
the majority reported nevertheless their symptoms to be triggered by allergen exposure.  
 
In conclusion, current rhinitis was reported in 25.0% of the 10-year-old children, and was 
associated with at least one allergy-related co-morbidity in 87.0%, as well as more often 
severe BHR and wheeze. Conjunctivitis and BHR was associated with rhinitis with allergic 
sensitization. The majority of the children had a mixed sensitization status, but symptoms 
triggered by pollen exposure only had the greatest impact on daily life activities.  
 
  13 
 ACKNOWLEDGEMENTS
We are deeply grateful to all the children and their parents for participating in the study. We 
are further indebted to all the research team involved in the study, especially to Petter 
Mowinckel, Solveig Knutsen, Geir Håland, Monica C. Munthe-Kaas, Chandra S. Devulapalli, 
Morten Pettersen, Berit Granum and Martinus Løvik. Declaration of all sources of funding: 
The ECA study was financially supported by the Norwegian Research Council, The 
University of Oslo, The Eastern Norway Regional Health Authority, Norwegian Institute of 
Public Health, The Norwegian Foundation for Health and Rehabilitation, The Norwegian 
Association for Asthma and Allergy, the Kloster foundation, Voksentoppen BKL, 
AstraZeneca, Ullevål University Hospital and Phadia.  
 
14 
 REFERENCES 
 
 1.  Lack G. Pediatric allergic rhinitis and comorbid disorders. J Allergy Clin Immunol 
2001: 108: S9-15. 
 2.  Leynaert B, Neukirch C, Kony S, Guenegou A, Bousquet J, Aubier M, et al. Association 
between asthma and rhinitis according to atopic sensitization in a population-based 
study. J Allergy Clin Immunol 2004: 113: 86-93. 
 3.  Weinmayr G, Forastiere F, Weiland SK, Rzehak P, Abramidze T, Annesi-Maesano I, et 
al. International variation in prevalence of rhinitis and its relationship with sensitisation 
to perennial and seasonal allergens. Eur Respir J 2008: 32: 1250-61. 
 4.  Spector SL. Overview of comorbid associations of allergic rhinitis. J Allergy Clin 
Immunol 1997: 99: S773-S780. 
 5.  Bousquet J, Gaugris S, Kocevar VS, Zhang Q, Yin DD, Polos PG, et al. Increased risk 
of asthma attacks and emergency visits among asthma patients with allergic rhinitis: a 
subgroup analysis of the investigation of montelukast as a partner agent for 
complementary therapy [corrected]. Clin Exp Allergy 2005: 35: 723-7. 
 6.  Prieto JL, Gutierrez V, Berto JM, Camps B. Sensitivity and maximal response to 
methacholine in perennial and seasonal allergic rhinitis. Clin Exp Allergy 1996: 26: 61-
7. 
 7.  Bousquet J, Bachert C, Canonica GW, Casale TB, Cruz AA, Lockey RJ, et al. Unmet 
needs in severe chronic upper airway disease (SCUAD). J Allergy Clin Immunol 2009: 
124: 428-33. 
 8.  Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, et al. Revised 
nomenclature for allergy for global use: Report of the Nomenclature Review Committee 
of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004: 113: 
832-6. 
 9.  Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic 
Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World 
Health Organization, GA(2)LEN and AllerGen). Allergy 2008:  8-160. 
 10.  Rondon C, Romero JJ, Lopez S, Antunez C, Martin-Casanez E, Torres MJ, et al. Local 
IgE production and positive nasal provocation test in patients with persistent nonallergic 
rhinitis. J Allergy Clin Immunol 2007: 119: 899-905. 
 11.  Bousquet J, Fokkens W, Burney P, Durham SR, Bachert C, Akdis CA, et al. Important 
research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN 
paper. Allergy 2008: 63: 842-53. 
 12.  Lodrup Carlsen KC, Haland G, Devulapalli CS, Munthe-Kaas M, Pettersen M, Granum 
B, et al. Asthma in every fifth child in Oslo, Norway: a 10-year follow up of a birth 
cohort study. Allergy 2006: 61: 454-60. 
  15 
  13.  Haland G, Carlsen KCL, Sandvik L, Devulapalli CS, Munthe-Kaas MC, Pettersen M, et 
al. Reduced lung function at birth and the risk of asthma at 10 years of age. N Engl J 
Med 2006: 355: 1682-9. 
 14.  Lodrup Carlsen KC, Pettersen M, Carlsen KH. Is bronchodilator response in 2-yr-old 
children associated with asthma risk factors? Pediatr Allergy Immunol 2004: 15: 323-
30. 
 15.  Bertelsen RJ, Lodrup-Carlsen K, Granum B, Carlsen KH, Haland G, Devulapalli CS, et 
al. Do allergic families avoid keeping furry pets? Indoor Air, doi:10.1111/j.1600-
0668.2009.00640.x 
 16.  Dreborg S, Frew A. Position Paper - Allergen Standardization and Skin-Tests. Allergy 
1993: 48: 49-82. 
 17.  Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung 
volumes and forced ventilatory flows. Report Working Party Standardization of Lung 
Function Tests, European Community for Steel and Coal. Official Statement of the 
European Respiratory Society. Eur Respir J Suppl 1993: 16: 5-40. 
 18.  Stanojevic S, Wade A, Cole TJ, Lum S, Custovic A, Silverman M, et al. Spirometry 
centile charts for young Caucasian children: the Asthma UK Collaborative Initiative. 
Am J Respir Crit Care Med 2009: 180: 547-52. 
 19.  Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, et al. 
Guidelines for methacholine and exercise challenge testing-1999. This official statement 
of the American Thoracic Society was adopted by the ATS Board of Directors, July 
1999. Am J Respir Crit Care Med 2000: 161: 309-29. 
 20.  Carlsen KH, Engh G, Mork M. Exercise-induced bronchoconstriction depends on 
exercise load. Respir Med 2000: 94: 750-5. 
 21.  O'Connor G, Sparrow D, Taylor D, Segal M, Weiss S. Analysis of dose-response curves 
to methacholine. An approach suitable for population studies. Am Rev Respir Dis 1987: 
136: 1412-7. 
 22.  Ait-Khaled N, Pearce N, Anderson HR, Ellwood P, Montefort S, Shah J. Global map of 
the prevalence of symptoms of rhinoconjunctivitis in children: The International Study 
of Asthma and Allergies in Childhood (ISAAC) Phase Three. Allergy 2009: 64: 123-48. 
 23.  Cibella F, Cuttitta G, La GS, Hopps MR, Passalacqua G, Pajno GB, et al. Bronchial 
hyperresponsiveness in children with atopic rhinitis: a 7-year follow-up. Allergy 2004: 
59: 1074-9. 
 24.  Marinho S, Simpson A, Lowe L, Kissen P, Murray C, Custovic A. Rhinoconjunctivitis 
in 5-year-old children: a population-based birth cohort study. Allergy 2007: 62: 385-93. 
 25.  Ciprandi G, Cirillo I, Vizzaccaro A, Tosca M, Passalacqua G, Pallestrini E, et al. 
Seasonal and perennial allergic rhinitis: is this classification adherent to real life? 
Allergy 2005: 60: 882-7. 
16 
  26.  Illi S, von Mutius E, Lau S, Niggemann B, Gruber C, Wahn U. Perennial allergen 
sensitisation early in life and chronic asthma in children: a birth cohort study. Lancet 
2006: 368: 763-70. 
 27.  Nelson HS, Szefler SJ, Jacobs J, Huss K, Shapiro G, Sternberg AL. The relationships 
among environmental allergen sensitization, allergen exposure, pulmonary function, and 
bronchial hyperresponsiveness in the Childhood Asthma Management Program. J 
Allergy Clin Immunol 1999: 104: 775-85. 
 28.  Wilson AF, Novey HS, Berke RA, Surprenant EL. Deposition of inhaled pollen and 
pollen extract in human airways. N Engl J Med 1973: 288: 1056-8. 
 29.  Rondon C, Dona I, Torres MJ, Campo P, Blanca M. Evolution of patients with 
nonallergic rhinitis supports conversion to allergic rhinitis. J Allergy Clin Immunol 
2009: 123: 1098-102. 
 30.  Witt CM, Ludtke R, Mengler N, Willich SN. How healthy are chronically ill patients 
after eight years of homeopathic treatment?--Results from a long term observational 
study. BMC Public Health 2008: 8:413.: 413. 
 31.  Shenfield G, Lim E, Allen H. Survey of the use of complementary medicines and 
therapies in children with asthma. J Paediatr Child Health 2002: 38: 252-7. 
 
 
 
 
  17 
 Table 1 Questions related to symptoms, triggers and medical treatment of rhinitis from the 
structured parental interview at the 10-year follow-up (the questions are translated from 
Norwegian) 
Interview questions Outcomes
Has the child had any of the following symptoms 
during the last 12 months (without a cold): a) 
runny nose, b) blocked nose, c) sneezing, d) 
itchy/runny eyes? 
Rhinitis (a, b and/or c) 
Conjunctivitis (d) 
What is causing the eye/nose symptoms? a) Not 
known b) Dog c) Cat d) Other furry pets e) Other 
causes f) Pollen from trees g) Other pollens h) 
Temperature changes/physical activity 
Unknown cause of symptoms (a) 
Symptoms related to furry pets (b,c, d) 
Symptoms related to pollens (f, g) 
Symptoms related to furry pets and pollens (b, c 
d and b, c) 
Symptoms related to other causes than allergens 
(e, h) 
 
Does the child have symptoms of rhinitis during 
a) the whole year, b) spring/summer or c) 
autumn/winter 
Time of year when symptoms occur 
How much impact have these symptoms had on 
daily life activities? a) No b) A little c) Moderate 
d) Severe   
Impact on daily activities  
Has the child ever been given the diagnosis 
hayfever/allergic rhinitis? 
Doctor diagnosed hayfever ever  
What kind of treatment has the child received due 
to symptoms of rhinitis? a) none b) don’t know c) 
topical antihistamines d) systemic antihistamines 
e) topical cortocisteroids f) systemic 
cortocisteroids g)sodium cromoglycateh) 
leukotriene antagonist i) immunotherapy j) 
homeopathy k) other alternative medicine 
Received medical treatment due to rhinitis (b-i) 
Alternative medicine (j-k) 
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 Table 2 Co-morbidities and clinical characteristics for children with and without current rhinitis at 10 
years of age (per cent unless otherwise stated) 
 
No rhinitis Current rhinitis 
n=761(75%) n=254 (25%) p-value
Gender (boys) 52.3   59.4    0.048
Conjunctivitis   3.7   75.6 <0.001 
Current asthma  10.3   31.7 <0.001
Current wheeze    7.6   32.1 <0.001
Otitis media last year    7.1     9.1   0.3 
Atopic eczema    
          -previous 12.8 20.1   0.004 
          -current 18.2 30.3 <0.001 
FEV1% predicted (mean (95% CI)) 99.6 (98.9, 100.3) 99.4 (98.1, 100.6)    0.8 
FEF50% predicted (mean (95% CI)) 98.8 (97.3, 100.4) 96.8 (94.3, 99.4)    0.2 
PD20 methacholine     
                  1μmol   5.8   17.5 
                  > 1 - 8 μmol 21.5   30.6 <0.001
                  > 8 μmol 72.7   52.0 
DRS (GM (95%CI))   1.07 (0.96, 1.20)     2.63 (2.09, 3.31) <0.001
Exercise induced bronchoconstriction 16.5   22.0   0.069 
Sensitization to inhalant allergens   
         - none 78.4   27.2 
         - seasonal    7.4   18.9 <0.001
         - perennial    6.2    6.7 
         - seasonal and perennial (mixed)   8.0   47.2 
Sensitization to food allergens    8.8   37.3 <0.001
Total IgE (GM (95%CI)) 35.7 (32.0, 39.7) 128.8 (105.4, 157.4) <0.001 
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 Table 3 Co-morbidities and characteristics reported causes of symptoms, duration, severity 
and rhinitis medication for children with non-allergic or allergic rhinitis (per cent unless 
otherwise stated) 
 
Rhinitis without
sensitization to 
inhalant allergens,
n=69
Rhinitis with
sensitization to 
inhalant
allergens, n=185
p-value
Gender (boys) 42.0 65.9 0.001
Conjunctivitis 47.8 85.9 <0.001 
Current asthma 25.0 34.3 0.2 
Current wheeze  23.5 35.3 0.08 
Otitis media last year  5.8 10.3 0.3 
Atopic eczema    
          -previous 18.8 20.5 0.8 
          -current 27.5 31.4 0.6 
FEV1% predicted (mean (95% CI)) 99.1 (96.8, 101.5) 99.5 (98.1, 100.6) 0.8 
FEF50% predicted (mean (95% CI)) 97.2 (92.8, 101.5) 96.7 (93.6, 99.8) 0.9 
PD20 methacholine     <0.001
                  1μmol 4.3 22.4  
                  > 1 - 8 μmol 24.6 32.8 
                  > 8 μmol 71.0 44.8 
DRS (GM (95%CI)) 1.25 (0.89, 1.76) 3.44 (2.60, 4.54) <0.001
Exercise induced bronchoconstriction 11.3 25.6  0.030
20 
 Table 4 Co-morbidities and clinical characteristics for children with symptoms of rhinitis 
triggered by pollen only or by pollen and furry pets (per cent unless otherwise stated) 
*The children who did not have symptoms in spring/summer season only had symptoms throughout the year 
(none had symptoms exclusively during winter season) 
Symptoms related
to pollen only
(n=125)
Symptoms related
to pollen and
furry pets (n=53) p
Gender (boys) 57.6 64.2 0.4 
Conjunctivitis 89.6 88.7 0.9 
Current asthma 28.5 47.1 0.018
Current wheeze  29.6 49.1 0.013
Otitis media last year  8.8 15.1 0.2 
Atopic eczema    
          -previous 17.6 22.6 0.8 
          -current 32.8 39.6 0.4 
FEV1% predicted  (mean (95% CI)) 99.8 (98.1, 101.4) 98.5(95.4, 101.6) 0.5 
FEF50% predicted  (mean (95% CI)) 98.6(94.8, 102.4) 91.4 (86.1, 97.8) 0.06 
PD20 methacholine     
                  1μmol 12.2 32.1 
                  > 1 - 8 μmol 27.6 32.1 0.002
                  > 8 μmol 60.2 35.8 
DRS (GM (95%CI)) 2.2(1.6, 3.0) 5.0(2.9, 8.6) 0.008
Exercise induced bronchoconstriction 17.2 25.0 0.3 
Sensitization to inhalant allergens   <0.001
         - none 18.4 7.5 
         - perennial  2.4 7.5 
         - seasonal  28.8 7.5 
         - seasonal and perennial (mixed) 50.4 77.4 
Total IgE (GM(95%CI)) 142.5(109.8, 184.9) 283.9(172.8, 466.2) 0.008
Symptoms in spring/summer only* 91.9 49.1 <0.001
Moderate/severe mpact on daily life activities 52.0 35.8    0.048
Doctor-diagnosed hayfever 54.8 84.6 <0.001
Any rhinitis treatment 84.0 90.6 0.3 
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 Follow-up, n=1019/1215 (84%)
Lung function
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Figure 1 Illustration of The Environment and Childhood Asthma (ECA) Study design 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
22 
   23 
 
0
20
40
60
80
100
120
0 1 2 3
Number of allergy-related co-morbities of current rhin
1.2
4
itis
13.0
44.1
28.0
13.8N
um
be
ro
fc
hi
ld
re
n
N
um
be
ro
fc
hi
ld
re
n
 
Figure 2 Bars referring to number of children with none, 1, 2, 3 or all 4 allergy-related 
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and otitis media during the last year (per cent given above each bar). 
 
 
 
 
 
 
 
 
 
 
 
 
 24
 
05010
0
15
0
20
0
25
0
Numberofchildren
63
.0
67
.7
72
.9
63
.4
68
.1
46
.2
45
.9
50
.0
69
.4
75
.0
66
.7
Timothy
Birch
Dog
Cat
Mugwort
DerP(HDM)
DerF(HDM)
Cockroach
Rabbit
Alternaria
Cladosporium
a)
b)
Nu
mb
er
 of
 se
ns
itiz
ing
 al
ler
ge
ns
1
2
3
4
5
6
7
8
9
10
11
02040608010
0
05010
0
15
0
20
0
25
0
63
.0
67
.7
72
.9
63
.4
68
.1
46
.2
45
.9
50
.0
69
.4
75
.0
66
.7
a)
b)
05010
0
15
0
20
0
25
0
63
.0
67
.7
72
.9
63
.4
68
.1
46
.2
45
.9
50
.0
69
.4
75
.0
66
.7
a)
b)
Nu
mb
er
 of
 se
ns
itiz
ing
 al
ler
ge
ns
1
2
3
4
5
6
7
8
9
10
11
02040608010
0
 
Fi
gu
re
 3
a)
 G
re
y 
ba
rs
 re
pr
es
en
ts
 th
e 
nu
m
be
r o
f c
hi
ld
re
n 
w
ith
 se
ns
iti
za
tio
n 
to
 e
ac
h 
of
 th
e 
sp
ec
ifi
c 
in
ha
la
nt
 a
lle
rg
en
s t
es
te
d 
w
ith
 in
cr
ea
si
ng
 
or
de
r f
ro
m
 th
e 
m
os
t c
om
m
on
 (t
im
ot
hy
 g
ra
ss
) t
o 
th
e 
le
as
t c
om
m
on
 (C
la
do
sp
or
iu
m
), 
an
d 
th
e 
bl
ac
k 
ba
rs
 re
pr
es
en
ts
 th
e 
nu
m
be
r o
f c
hi
ld
re
n 
w
ith
 m
on
os
en
si
tiz
at
io
n.
 T
he
 d
ot
s r
ep
re
se
nt
 th
e 
nu
m
be
r o
f c
hi
ld
re
n 
fo
r e
ac
h 
sp
ec
ifi
c 
se
ns
iti
zi
ng
 a
lle
rg
en
 w
ho
 a
ls
o 
ha
ve
 c
ur
re
nt
 rh
in
iti
s (
th
e 
pe
rc
en
ta
ge
 o
f c
ur
re
nt
 rh
in
iti
s i
s g
iv
en
 a
bo
ve
 e
ac
h 
ba
r)
. b
)G
re
y 
ba
rs
 re
pr
es
en
ts
 th
e 
nu
m
be
r o
f c
hi
ld
re
n 
w
ho
 w
er
e 
se
ns
iti
ze
d 
fr
om
 1
 to
 a
ll 
th
e 
11
 in
ha
la
nt
 a
lle
rg
en
s t
es
te
d.
 T
he
 d
ot
s r
ep
re
se
nt
 th
e 
nu
m
be
r o
f c
hi
ld
re
n 
w
ho
 w
ith
 c
ur
re
nt
 rh
in
iti
s
 0
20
40
60
80
100
Conjunctivitis*
Current asthma
Current wheeze
Current atopic eczema
Otitis media last yearBHR
EIB
FEV1=<90
Allergic sensitization*
Allergen triggered rhinitis
Unknown or other triggers than allergens
Figure 4 Radarplot of distribution of co-morbidities and clinical characteristics in children 
with rhinitis triggered by allergens (n=194) or unknown or other triggers than allergens 
(n=60). BHR presented as PD20 1 μmol methacholine. The scale gives the percentage of 
children with each co-morbidity or phenotype 
* for p< 0.001, or otherwise no significant difference between the groups 
  25 

IV

GENDER DIFFERENCES IN INDOOR ALLERGEN EXPOSURE AND 
ASSOCIATION WITH CURRENT RHINITIS
 
Randi J. Bertelsen1, Christine Instanes2, Berit Granum1, Karin C. Lødrup Carlsen3,4, Geir 
Hetland5, Kai-Håkon Carlsen4,6, Petter Mowinckel3, Martinus Løvik1, 7
 
1 Department of Environmental Immunology, Division of Environmental Medicine, 
Norwegian Institute of Public Health 
2 Department of Chemical Toxicology, Division of Environmental Medicine, Norwegian 
Institute of Public Health 
3 Department of Paediatrics, Oslo University Hospital, Ullevål 
4 Faculty of Medicine, University of Oslo 
5 Department of Immunology and Transfusion Medicine, Oslo University Hospital, Ullevål 
6 Department of Paediatrics, Voksentoppen, Oslo University Hospital, Rikshospitalet 
- all Oslo, Norway 
7  P Department of Cancer Research and Molecular Medicine, Norwegian University of Science 
and Technology, Trondheim, Norway 
 
Corresponding author: Randi Jacobsen Bertelsen, Norwegian Institute of Public Health, 
Department of Environmental Immunology, Division of Environmental Medicine, P.O. Box 
4404 Nydalen, NO-0403 Oslo, Norway. Telephone: +47 21 07 63 27, fax: +47 21 07 66 86. 
E-mail: randi.jacobsen.bertelsen@fhi.no 
 
 1
Abstract
Background Differences between boys and girls in allergic manifestations are well known, 
and this difference is possibly not attributed to biological differences alone.  
Objective We therefore investigated whether boys and girls could be exposed to different 
allergen levels at home and whether the indoor allergen levels could be differently associated 
with rhinitis in boys and girls at 10 years of age.  
Methods Cat, dog and house dust mite allergen (HDM) levels in mattress dust and interview 
data regarding current allergic disease were retrieved for 797 10-year old children (360 girls) 
in The Environment and Childhood Asthma Study in Oslo.  
Results Cat and dog allergen levels were highest for children with current pet ownership. 
However, also those who had previously kept pets or who had regular contact with pets 
outside their home had higher allergen levels compared to those who had never owned pets. 
Girls had higher levels of cat and dog allergens in their mattress dust compared to boys, 
regardless of pet ownership, whereas no difference was seen for HDM allergen (Der p1) 
levels. Of the 190 (23.8%) children reporting current rhinitis, 144 were sensitized to at least 
one allergen. The adjusted odds ratio for current rhinitis increased with 1.20 (95% CI: 1.01, 
1.42) per 1 μg/g dust increase in Der p1 levels for girls (p=0.037), but not for boys (p=0.91). 
The children with unknown triggers of rhinitis had significantly higher dog allergen 
concentrations in their mattress dust (GM: 0.67 (95% CI: 0.37, 1.22) μg/g dust) compared to 
the children with perceived rhinitis triggers (0.34 (0.25, 0.46)), p=0.050.  
Conclusion Girls had higher levels of pet allergens in mattress dust compared to boys, 
whereas no difference was seen for Der p1 allergen levels. Nevertheless, increasing levels of 
Der p1 significantly increased the risk of current rhinitis, but in girls only.  
 
Keywords: gender, house dust mite, indoor allergens, pet keeping, rhinitis  
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Introduction
Rhinitis is one of the atopic manifestations in children, associated with asthma [1, 2] and 
bronchial hyperresponsiveness (BHR) [3], but can be present independently of allergic 
sensitization. Exposure to indoor allergens such as animal dander and house dust mite (HDM) 
increases the risk for both asthma and rhinitis [4]. Indoor allergens may exacerbate symptoms 
and increase BHR also in non-asthmatic subjects with allergic rhinitis [4, 5]. Thus, allergen 
avoidance is important to reduce symptoms in sensitized individuals. The observed inverse 
association between pet keeping and sensitization to pet allergens [6] has been attributed to 
pet avoidance in allergic families [6, 7]. We have previously reported that families of children 
with doctor confirmed allergic rhinitis were less likely to acquire cats and dogs during the 10 
first years of life [8]. However, to be aware of all allergen exposure is virtually impossible 
since pet allergens are ubiquitously present in public areas and passively transferred to homes 
without pets [9, 10]. Moreover, even low allergen levels may induce symptoms in sensitized 
patients, as was shown by demonstrating nasal symptoms in patients challenged with 
concentrations of cat allergen (Fel d1) comparable to allergen levels in homes without cats 
[11].  
In many populations mites are common with a corresponding high population 
prevalence of HDM sensitization [12]. In other populations, such as many areas of 
Scandinavia, HDM allergens are rarely found in the mattresses of children’s bed [13, 14]. 
Exposure to HDM is frequently a low grade chronic exposure occurring overnight in bed, and 
controlled trials of primary avoidance of HDM have been relatively unsuccessful [15]. 
However, even low HDM allergen (Der p1) levels have been associated with allergic 
sensitization [14, 16], but also with nasal symptoms [17] and asthma exacerbation [18] in 
patients without detectable serum specific immunoglobulin E (s-IgE) to HDM.  
In pre-puberty, boys have more often allergic disease than girls, whereas the gender 
association is reversed after puberty with asthma more commonly found in young women 
[19]. However, boys and girls differ not only in biology, but also in their behaviour and 
interests, which may affect the level of allergen exposure. Differences in risk factors and 
susceptibility to pet exposure have been reported [20]. In the present cohort, families in which 
the index child was a girl were more likely to acquire furry pets than families in which the 
index child was a boy [8].  
It is not clear to what extent gender interacts with the associations between allergen 
exposure and allergic disease in school age. The aims of the present study were therefore first 
to describe the level of exposure to indoor allergens for girls and boys, and secondly to assess 
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whether there was a gender interaction between indoor allergen levels and the association 
with rhinitis and BHR.    
4 
Material and methods 
Subjects
The present study reports results from the 10-year follow-up of the birth cohort ‘The 
Environment and Childhood Asthma Study’ (ECA) initiated in Oslo in 1992-1993. In total 
1019 (84%) of 1215 invited children participated. As previously described [21], the follow-up 
study included extended clinical examination and a parental structured interview. The parents 
of the 1019 participating children were asked to collect dust from the child’s mattress. Of 
these, 154 did not want to collect a dust sample, 27 did not return the sample and 41 samples 
could not be analysed due to insufficient amounts of dust. The remaining 797 children were 
included in the present study.   
The 797 children with a mean age of 10.6 years (min: 8.8, max: 12.3) had less often 
cats at home (18% vs 26%, p=0.007), less often parents who smoked (38% vs 47%, p=0.02), 
and less often parents with higher education than the 222 non-included children (no dust 
sample). They were otherwise comparable in regard to the children’s and the parents’ allergic 
disease, family income, type of housing, and pet ownership (other than cats). 
Written informed consent was obtained from the parents, and the study was approved 
by the Regional Committee for Ethics in Medical Research and the Norwegian Data 
Inspectorate and reported to the Norwegian Biobank Registry. 
Dust sampling and extraction 
The families were instructed not to change the linen on the child’s bed for one week prior to 
the sampling of the mattress dust. The dust was collected by vacuuming the mattress for four 
minutes with vacuum cleaners equipped with a special dust collector (P-B Miljø A/S, 
Bjerringbro, Denmark) [22]. At the laboratory, the dust was vacuumed (sieved) through a 
filter with pore-size 0.3 μm, and the fine fraction of the dust was weighed and extracted in 
phosphate-buffered saline with 0.02% NaN3 to a final concentration of 25 mg/ml and agitated 
in room temperature overnight. The extracted samples were then stored at -20ºC until 
analysis.  
Analyses of cat, dog and mite allergens 
The concentrations of the major cat (Felis domesticus Fel d1), dog (Canis familiaris Can f1) 
and mite (Dermatophagoides pteronyssinus Der p1) allergens were determined by enzyme-
linked immunosorbent assay (ELISA) following the manufacturer’s instructions (Indoor 
Biotechnologies, Clewyd, UK) [23] and as described in detail elsewhere [24]. Results were 
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given as μg allergen per gram dust. The detection limits of the ELISA were determined 
according to the standard curve for each run. Values below the detection limit were, for 
statistical purposes, given values of 2/3 of the detection limits: 0.12 μg/g for Der p1, 0.03 
μg/g for Can f1 and 0.20 μg/g for Feld d1. For the dog allergen assay 57 samples were below 
the detection limit, 215 samples for cat allergen and 697 for HDM allergen (Der p1).  
 
Clinical examination at the 10-year follow-up 
Two clinical examinations were performed 2-7 days apart and at least four weeks after any 
respiratory tract infection. The examinations included blood tests, skin prick tests for allergic 
sensitization, lung function by forced flow-volume measurements and bronchial 
hyperresponsiveness measured by methacholine challenge test and a treadmill exercise test. 
Skin prick tests (SPT) were performed according to European standards [25] with the 
following standardized allergen extracts from ALK (Soluprick®, ALK-Abello, Denmark): 
house dust mites (Dermatophagoides pteronyssinus and Dermatophagoides farinae), German 
cockroach, dog, cat and rabbit, birch, timothy (grass) and mugwort pollen, moulds 
(Cladosporium herbarium and Alternaria), egg white, milk, peanut and codfish. SPT were 
considered positive with a wheal diameter at least 3 mm larger than the negative control 
(saline).  
Specific serum IgE (sIgE) was measured with a radioallergosorbent fluorescence 
immunoassay (ImmunoCAP® system, Phadia, Uppsala, Sweden). Specific IgE was analysed 
with the same panel of allergens as for SPT, and considered positive when sIgE 0.35 kU/L. 
Baseline spirometry was performed according to European standards [26] on a Sensor 
Medics Vmax 20c instrument (SensorMedics Diagnostics, Yorba Linda, CA, USA) prior to 
and after methacholine and exercise challenge tests on separate days. Short and long-acting 
beta-2 receptor agonists were withheld for at least 3 and 18 hours, respectively as were other 
relevant medications according to international guidelines prior to investigations [21]. 
The methacholine challenge test was measured as PD20 methacholine according to 
international guidelines [27], by inhalation of doubling doses of methacholine, nebulised by 
the Spira nebuliser (Spira Respiratory Care Center LtD, Hämeenlinna, Finland). The response 
was reported as the dose of methacholine that caused a fall in FEV1 (forced expiratory volume 
in one second) of 20% from the (post-saline) baseline value (PD20 methacholine). A 
standardized exercise test [28] was performed on the second day by a 6-8 minutes treadmill 
run at 95% estimated maximum pulse level with 5.5% inclination. The exercise test was 
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considered positive for exercise-induced bronchoconstriction with a fall in FEV1>10% of 
baseline FEV1 measured 3-20 minutes after running had ceased. 
Parental structured interview 
The parental structured interview included central ISAAC questions related to airways 
symptoms of the child, including rhinitis. The questions related to rhinitis included perceived 
triggers of rhinitis (furry pets, pollens, temperature changes, physical activity or unknown), in 
which seasons the symptoms occurred (all year, spring/summer or autumn/winter) and the 
impact the rhinitis symptoms had on daily life activities (none, some, moderate or severe). 
Information about pet ownership and contact with pets outside the home was retrieved from 
the questions: “Do you currently keep a dog?” and “Is the child in regular contact with a 
dog?” The same questions were asked for cats and for other types of furry pets (rodents).  
 
Definitions
Current rhinitis was present in a child reporting at least one of the following symptoms 
during the last 12 months (without a cold): runny nose, blocked nose, or sneezing. Current
conjunctivitis required a report of itchy/runny eyes within the last 12 months. 
Rhinitis with allergic sensitization was defined by symptoms of rhinitis combined with 
at least one positive SPT and/or sIgE to any of the inhalant seasonal (pollen or moulds) or 
perennial (mite, cat, dog, rabbit or cockroach) allergen. 
BHR was defined as a methacholine dose-response slope (DRS) (higher DRS 
indicating more BHR) calculated from each individual as per cent decline in FEV1 after the 
final dose of methacholine divided by the cumulative dose of methacholine inhaled [29].  
Asthma was defined by the presence of at least two of the three criteria; asthma 
symptoms, doctor’s diagnosis of asthma and use of asthma medication. Current asthma was 
defined as asthma plus at least one of the following criteria; asthma symptoms or use of 
asthma medication within the last 12 months and a positive exercise challenge test at the 10 
year follow-up visit [21]. 
 
Statistical analyses
Categorical variables were compared using Pearson’s chi-square test and linear-by-linear 
association for trends with more than two categories. One-way ANOVA was used to compare 
allergen concentrations (log-transformed and presented as geometric mean (GM) and 95% 
confidence intervals (95% CI)), and two-way ANOVA to adjust for pet keeping. To assess 
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whether gender interacted with the indoor allergen exposure levels, multivariate regression 
analyses were performed for rhinitis, DRS, impact on daily life activities and rhinitis with 
unknown rhinitis triggers. We also included current asthma and reported pet avoidance in the 
multivariate models as these have been confirmed to be associated with rhinitis for children in 
this cohort.. DRS was log-transformed due to skewed distribution, and due to the violation of 
normality and homoscedasticity assumptions. A robust regression was performed by using 
Huiber’s method [30]. The result of the regression analysis was back-transformed for DRS. 
The final model for unknown rhinitis triggers was ascertained with the Akaike Information 
Criterion (AIC) [31]. The criterion for linearity for the logistic regression model, and the 
condition for normally distributed residuals of the dependent variables in the linear regression 
model, were both fulfilled. Cat, dog and HDM allergens were, therefore, used as continuous 
variables without log-transformation in the logistic and linear regression models. All models 
were tested for confounding and interaction. P-values  0.05 were considered significant. 
Statistical analyses were performed with Statistical Package for Social Sciences (SPSS 
version 14.0, SPSS Inc., Chicago, Illinois, USA). For the robust regression Number Cruncher 
Statistical System (NCSS version 2007, Kaysville, Utah, USA) was applied. 
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Results
Current rhinitis was found in 190/797 (23.8%) of the 10-year-old children. Boys had 
significantly more often current asthma, rhinitis, and wheeze as well as higher DRS compared 
to the girls (table 1). Also, the boys were significantly more often sensitized to perennial, 
seasonal and food allergens than the girls (table 1).  
 
Cat and dog allergen levels in mattress dust 
The highest cat and dog allergen levels were found in homes of cat-owners (18.2%) and dog-
owners (14.3%); GM (95% CI): 37.9 (26.3, 54.7) and 32.2 (26.1, 44.8) μg allergen/g dust, 
respectively (figure 1). In mattresses of families who previously (but not currently) owned 
cats (38/640, 5.9%) or dogs (41/672, 6.1%), the cat and dog allergen levels were significantly 
higher than for those who had never kept pets (figure 1). The cat and dog allergen levels were 
also significantly higher in the mattresses of children with regular contact with cats or dogs 
outside their home compared to children with no ownership or regular contact with these 
animals (both p<0.001) (figure 1). 
Girls compared to boys reported significantly more often cats at home (21.2% vs 
15.9%) and contact with cats outside home (8.4% vs 6.7%), overall p=0.03. Whereas for cat 
ownership alone the difference was no statistically significant (p=0.062). No statistically 
significant gender difference was seen for dog ownership or contact (table 1), and neither for 
dog ownership alone, p=0.4. Nevertheless, the levels of both cat and dog allergens in mattress 
dust was significantly higher for girls compared to boys (table 1). The difference remained 
significant for cat (p<0.001) and dog allergen levels (p=0.001), after adjustment for pet 
contact and ownership. 
 
Allergic sensitization and allergen exposure
Compared to non-sensitized children (any allergen), the 34.0% of the children sensitized to at 
least one inhalant allergen had significantly lower levels of cat allergens: GM (95% CI): 0.99 
(0.77, 1.26) μg Fel d1/g dust for sensitized children vs 1.54 (1.27, 1.87) for non-sensitized 
children, p=0.006. The difference was also significant for dog allergen levels in mattress dust 
of sensitized children: GM: 0.41 (0.32, 0.53) μg Can f1/g dust vs non-sensitized children: 
0.75 (0.62, 0.91), p<0.001 (table 2). Also significantly so after adjusting for dog ownership, 
whereas for cat allergen levels the difference was no longer significant after adjusting for cat 
ownership (table 2). 
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The Der p1 allergen levels were generally low in mattresses, and 87.7% of the samples 
had levels below the detection limit of the assay. Nevertheless, the geometric mean Der p1 
allergen level in mattress dust of children sensitized to Der p1 (8.8%) was significantly higher 
than for children without Der p1 sensitization: 0.21 (0.16, 0.28) and 0.16 (0.15, 0.17) μg/g 
dust, respectively, p=0.004.  
 
Allergen exposure, current rhinitis and BHR 
Among girls and boys with current rhinitis, boys were more often sensitized to inhalant 
allergens (83.9%) than girls (62.5%) (p=0.001). However, boys and girls did not differ in 
reports of conjunctivitis symptoms, the types of triggers related to their symptoms or the 
impact the symptoms had on daily life activities (all p0.4).  
Children with current rhinitis had significantly less often pets at home and lower pet 
allergen levels than among children without rhinitis, 0.97 (0.72, 1.29) vs 1.46 (1.22, 1.74) μg 
cat allergen/g dust for children with vs without current rhinitis, respectively (p=0.023), and 
similar for dog allergen: 0.40 (0.30, 0.52) vs 0.70 (0.58, 0.84) μg dog allergen /g dust, 
respectively (p=0.002) (table 2).  
In the multivariate logistic regression model, gender interacted with asthma and HDM 
allergen exposure. The adjusted odds ratio for current rhinitis in girls increased with 1.20 
(95% CI: 1.01, 1.42) per μg increase in Der p1 allergen level, p=0.037, whereas no 
association was seen for boys (p=0.91) (table 3). No significant association was seen for cat 
and dog allergen levels and current rhinitis symptoms. 
In the multivariate linear regression model with logDRS as dependent variable, 
allergic sensitization interacted with dog allergen levels. DRS (back-transformed values) 
decreased with 0.99 (regression coefficient (b), (95% CI: 0.98, 1.00), p=0.004) per 1 μg 
increase in dog allergen levels, for children with allergic sensitization (table 4). The 
association was not significant for children without allergic sensitization (p=0.25). 
HDM, cat and dog allergen levels in mattress dust were not associated with the impact 
the rhinitis symptoms had on daily life activities (none/some vs moderate/severe) (results not 
shown). 
 
Cat and dog allergen exposure in relation to reported triggers of rhinitis 
Children reporting at least one perceived rhinitis trigger (n=149) reported mostly symptoms 
related to allergen exposure (97.3%), most often pollen (62.0%) or both pollen and furry pets 
(28.3%), and only a few reported symptoms related to furry pets only (7.0%). Children with 
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unknown triggers (n=41) were more likely to have symptoms throughout the year (55.6%) 
compared to those with perceived rhinitis triggers (24.6%), p<0.001. The children with 
unknown triggers were also less likely to be allergically sensitized (34.1%) compared to those 
with perceived rhinitis triggers (87.2%), p<0.001.  
The children with unknown triggers of rhinitis had significantly higher levels of dog 
allergen in their mattress dust [GM: 0.67 (95%CI: 0.37, 1.22) μg/g dust] compared to the 
children with perceived rhinitis triggers [0.34 (0.25, 0.46)], p=0.050 (two-way ANOVA). 
However, in the multivariate logistic regression model with indoor allergen levels, allergic 
sensitization and reported pet avoidance as potential explanatory variables, only Der p1 
allergen levels in interaction with pet avoidance was significant determinants of rhinitis with 
unknown triggers. The adjusted odds ratio for rhinitis with unknown triggers increased with 
2.52 (95% CI: 1.26, 5.03) per 1 μg increase in Der p1 allergen levels (p=0.01), but only for 
children with reported pet avoidance, whereas no association was seen for children without 
reported pet avoidance (p=0.82).  
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Discussion
In the present study, girls were exposed to higher levels of both cat and dog allergens than 
boys, a difference that could not be explained by pet ownership. Children with rhinitis had 
lower levels of pet allergen in the mattresses than children without rhinitis. HDM allergen was 
only detectable in 12% of the mattress dust samples. Nevertheless, increasing HDM allergen 
levels significantly increased the risk of current rhinitis, but in girls only, and were associated 
with rhinitis caused by unknown triggers in children with reported pet avoidance.  
Higher cat and dog allergen levels in mattresses of girls compared to boys, also after 
adjustment for pet ownership, have to our knowledge not been reported previously. However, 
a recent study from Sweden reported more cat keeping among girls than boys, with a 
significant interactive effect on the risk for current wheeze for girls only [20]. Both studies 
may point to a greater inclination among girls to be with and cuddle pets. The higher allergen
level in the present study may also be related to the tendency for girls to decorate their room 
with plush animals, fluffy pillows and carpets which may act as reservoirs for the allergens 
[32, 33]. Carpets on the bedroom floor were, in the present study, more often reported by the 
girls than the boys (13.2% vs 9.3%, respectively, p=0.08). Furthermore, associations between 
allergic sensitization in young children and soft toys in their bed have been reported by others 
[34], albeit without describing allergen levels or gender related differences.  
Children with regular contact with pets or who were previous pet owners had higher 
allergen levels in their mattress dust compared to children who had never kept pets, which is 
consistent with earlier reports [35-37]. These findings illustrate the importance of allergen 
contamination on the clothes of individuals without pets at home [32] and the difficulty in 
reducing the allergen load even after removing furry pets [38]. The presence of pet allergens 
in homes without pets and even more the presence of HDM allergen, may render the patients 
unable to relate the allergen exposure to their symptoms. Thus, the association with higher 
dog allergen levels in mattress dust of children with unknown factors of rhinitis could 
potentially be a cause of their symptoms. It is also compatible with the finding that these 
children often had rhinitis symptoms throughout the year.  
Increasing dog allergen levels were associated with reduced DRS (less BHR), which 
probably reflects the tendency to avoid pets if the child has rhinitis. We have previously 
reported more BHR among children with than without rhinitis (submitted manuscript). In 
addition, a doctor confirmed diagnosis of allergic rhinoconjunctivitis prior to the 10-year 
follow-up study was the strongest predictor for never having kept cats and dogs [8]. This may 
be the reason why the children with current rhinitis at 10 years of age were also found to have 
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lower pet allergen levels in their mattress dust compared to children without rhinitis. 
Moreover, in the multivariate analysis, reported pet avoidance, but not cat and dog allergen 
levels, was significantly associated with current rhinitis symptoms.  
The interaction between reported pet avoidance and HDM (Der p1) allergen levels as 
determinant for rhinitis with unknown triggers is difficult to explain. The result is the opposite 
of what one would expect if the families with reported pet avoidance also were likely to make 
efforts to reduce the overall allergen load (such as regular vacuuming of the mattresses). 
However, even in intervention studies it has been difficult to reduce the HDM allergen levels 
[15].  
The levels of Der p1 in the present study were low, but in line with previous reports 
from Norway [16, 39]. Nevertheless, the children with Der p1 sensitization had higher Der p1 
levels in mattress dust compared to children without sensitization, as has also previously been 
described in other Norwegian [16] and Swedish [14] study populations. The association 
between allergen levels and sensitization was seen regardless of gender, whereas the 
association between mattress dust levels of Der p1 and current rhinitis was significant for girls 
only. The reason why girls, but not boys, should experience current rhinitis symptoms due to 
HDM allergen exposure is difficult to explain, but one possibility is that the effect of HDM 
allergen exposure on rhinitis symptoms for boys is masked by the strong association between 
asthma and rhinitis.. Nevertheless, our findings point to the importance of HDM allergen 
related symptoms, even for allergen levels that are much lower than has conventionally been 
assumed to be important for disease development.  
 
Strengths and limitations of the present study 
In the present study, the dust samples were sieved and the allergen concentrations were 
measured in the fine fraction of the dust. Allergens from cat and dog are found to mainly bind 
to particles that are part of the fine fraction of the dust [40], and the sieved dust are thus 
believed to be representative for the airborne component of the sample. HDM allergens, on 
the other hand, are more often associated with mite feces that are usually larger particles and 
less likely to be airborne. Thus, although previous reports from Norway also have reported 
few mattress dust samples with detectable HDM allergen levels [16, 39], the sieving of the 
dust samples may have reduced the quantity of HDM allergens that could be measured.  
The ECA study is a well characterised birth cohort with a high follow-up rate and 
includes environmental and detailed clinical characteristics at several time points. The rhinitis 
definition was based upon ISAAC questionnaires, but with no clinical examination of the 
 13
nasal cavity. However, we included objective measures of airways inflammation such as 
exhaled nitric oxide, consistent with the rhinitis diagnosis in the same population (described 
in detail elsewhere) (In press, Pediatr Allergy Immunol).  
In conclusion, girls had higher concentrations of both cat and dog allergens in their 
mattresses compared to boys. This was not caused by pet ownership, but may be due to 
behavioural differences between the genders. Even in our population with HDM detection in 
less than 20% of children, exposure to low levels of HDM allergen was associated with 
current rhinitis in girls and with rhinitis triggered by unknown factors in children with 
reported pet avoidance.  
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Table 3 Variables associated with current rhinitis. Due to significant gender interaction, the 
results are given separately for boys and girls.  
aOR = adjusted odds ratio. Cat and dog allergen levels was not significant determinants of current rhinitis in the 
multivariate models 
Boys (n=467)  Girls (n=360)  
Variables associated with 
current rhinitis aOR(95% CI) P  aOR(95% CI) P
Allergic sensitization 13.36 (7.46, 23.92) <0.001 8.70 (4.69, 16.13) <0.001 
Current asthma   2.76 (1.46, 5.22)   0.006 0.66 (0.26, 1.67)   0.38 
HDM allergen (1μg/g dust)   1.00 (0.94, 1.06)   0.91 1.20 (1.01, 1.42)   0.037 
Reported pet avoidance   2.15 (1.24, 3.72)   0.002 8.70 (4.69, 16.13) <0.001 
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Table 4 Linear regression analyses of determinants of DRS (higher DRS indicates more 
BHR) in 10-year old children. Due to significant interaction between allergic sensitization and 
dog allergen levels, results are given separately according to allergic sensitization (to any 
inhalant allergen) 
 b, regression coefficient. Gender, HDM and cat allergen exposure was not significant determinants for DRS 
No allergic sensitization Allergic sensitization Variables associated with 
increase in DRS b 95% CI P  b SE P
Intercept  0.12   0.55   
Dog allergen (1μg/g dust) 1.00 (1.00, 1.00) 0.25 0.99 (0.98, 1.00) 0.004 
Current asthma 1.26 (1.03, 1.53) 0.02 2.06 (1.58, 2.68) <0.001
Current rhinitis 1.15 (0.94, 1.41) 0.18 1.26 (1.00, 1.59) 0.055 
Reported pet avoidance 1.12 (0.97, 1.29) 0.12 1.19 (0.94, 1.50) 0.15 
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 Figure 1: Differences in dog allergen levels [geometric mean (bars) with 95% confidence interval (CI)]
between children with no dog contact or ownership ever, previous dog ownership, contact with dogs 
outside home and current dog ownership, and similar for cat allergens.  
* P <0.001  
22 
Appendix A: Parts of questionnaire at birth (in Norwegian) 









Appendix B: Parts of the interview form at age 10 years (in Norwegian) 







